BCB Bancorp (BCBP) 10-Q 4 May 22 2022 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2022	May 02, 2022
Document And Entity Information [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	0-50275
Entity Registrant Name	BCB Bancorp, Inc.
Entity Incorporation, State or Country Code	NJ
Entity Tax Identification Number	26-0065262
Entity Address, Address Line One	104-110 Avenue C
Entity Address, City or Town	Bayonne
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07002
City Area Code	201
Local Phone Number	823-0700
Title of 12(b) Security	Common Stock, no par value
Security Exchange Name	NASDAQ
Trading Symbol	BCBP
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		16,991,284
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Entity Central Index Key	0001228454
Amendment Flag	false

Consolidated Statements of Fina

Consolidated Statements of Financial Condition - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
ASSETS
Cash and amounts due from depository institutions	$ 8,448	$ 9,606
Interest-earning deposits	388,205	402,023
Total cash and cash equivalents	396,653	411,629
Interest-earning time deposits	735	735
Debt securities available for sale	86,307	85,186
Equity investments	21,269	25,187
Loans held for sale	325	952
Loans receivable, net of allowance for loan losses of $33,980 and $37,119, respectively	2,395,930	2,304,942
Federal Home Loan Bank of New York stock, at cost	6,128	6,084
Premises and equipment, net	11,646	12,237
Accrued interest receivable	9,593	9,183
Other real estate owned	75	75
Deferred income taxes	13,016	12,959
Goodwill and other intangibles	5,417	5,431
Operating lease right-of-use assets	11,883	12,457
Bank-owned life insurance ("BOLI")	73,240	72,485
Other assets	8,093	7,986
Total Assets	3,040,310	2,967,528
LIABILITIES
Non-interest-bearing deposits	621,402	588,207
Interest bearing deposits	2,009,773	1,973,195
Total deposits	2,631,175	2,561,402
FHLB advances	71,848	71,711
Subordinated debentures	37,333	37,275
Operating lease liability	12,180	12,752
Other liabilities	11,615	10,364
Total Liabilities	2,764,151	2,693,504
STOCKHOLDERS' EQUITY
Preferred stock: $0.01 par value, 10,000,000 shares authorized; issued and outstanding 2,645 shares of Series D 4.5%, Series H 3.5% and Series I 3.0%, (liquidation value $10,000 per share) noncumulative perpetual preferred stock at March 31, 2022 and 2,916 shares of Series D 4.5%, Series G 6%, Series H 3.5% and Series I 3% (liquidation value $10,000 per share) noncumulative perpetual preferred stock at December 31, 2021
Additional paid-in capital preferred stock	26,213	28,923
Common stock: no par value; 40,000,000 shares authorized; issued 19,753,295 and 19,708,375 at March 31, 2022 and December 31, 2021, respectively, outstanding 16,984,538 and 16,940,133, at March 31, 2022 and December 31, 2021, respectively
Additional paid-in capital common stock	194,222	193,927
Retained earnings	88,132	81,171
Accumulated other comprehensive loss	(1,275)	1,128
Treasury stock, at cost, 2,768,757 and 2,768,242 shares at March 31, 2022 and December 31, 2021, respectively	(31,133)	(31,125)
Total Stockholders' Equity	276,159	274,024
Total Liabilities and Stockholders' Equity	$ 3,040,310	$ 2,967,528

Consolidated Statements of Fi_2

Consolidated Statements of Financial Condition (Parenthetical) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Loans receivable, allowance for loan losses	$ 33,980	$ 37,119
Preferred stock, par value per share	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	2,645	2,916
Preferred stock, shares outstanding	2,645	2,916
Common stock, no par value	$ 0	$ 0
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	19,753,295	19,708,375
Common stock, shares outstanding	16,984,538	16,940,133
Treasury stock, shares	2,768,757	2,768,242
Series D Preferred Stock [Member]
Preferred stock, dividend rate	4.50%	4.50%
Preferred stock, liquidation preference per share	$ 10,000	$ 10,000
Series G Preferred Stock [Member]
Preferred stock, dividend rate		6.00%
Preferred stock, liquidation preference per share		$ 10,000
Series H Preferred Stock [Member]
Preferred stock, dividend rate	3.50%	3.50%
Preferred stock, liquidation preference per share	$ 10,000	$ 10,000
Series I Preferred Stock [Member]
Preferred stock, dividend rate	3.00%	3.00%
Preferred stock, liquidation preference per share	$ 10,000	$ 10,000

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Interest and dividend income:
Loans, including fees	$ 26,321	$ 26,863
Mortgage-backed securities	159	206
Other investment securities	948	784
FHLB stock dividends and other interest earning assets	296	222
Total interest income	27,724	28,075
Deposits:
Demand	758	1,198
Savings and club	108	118
Certificates of deposit	980	1,992
Total deposits	1,846	3,308
Borrowings	806	1,205
Total interest expense	2,652	4,513
Net interest income	25,072	23,562
(Reversal) provision for loan losses	(2,575)	1,865
Net interest income after (reversal) provision for loan losses	27,647	21,697
Non-interest income:
Fees and service charges	1,214	1,111
BOLI income	755	701
Gain on sales of loans	65	274
Realized and unrealized (losses) on equity investments	(2,685)	(196)
Other	51	60
Total non-interest income	(600)	1,950
Non-interest expense:
Salaries and employee benefits	6,736	6,545
Occupancy and equipment	2,695	2,953
Data processing and communications	1,465	1,456
Professional fees	494	412
Director fees	321	247
Regulatory assessments	304	376
Advertising and promotional	141	83
Other real estate owned, net	1	4
Loss from extinguishment of debt		540
Other	802	967
Total non-interest expense	12,959	13,583
Income before income tax provision	14,088	10,064
Income tax provision	4,136	2,947
Net Income	9,952	7,117
Preferred stock dividends	276	283
Net Income available to common stockholders	$ 9,676	$ 6,834
Net Income per common share-basic and diluted
Basic	$ 0.57	$ 0.40
Diluted	$ 0.56	$ 0.40
Weighted average number of common shares outstanding
Basic	16,980	17,115
Diluted	17,343	17,232

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Consolidated Statements of Comprehensive Income [Abstract]
Net Income	$ 9,952	$ 7,117
Unrealized losses on available-for-sale debt securities:
Unrealized holding losses arising during the period	(3,195)	(192)
Tax Effect	792	48
Other comprehensive loss	(2,403)	(144)
Comprehensive income	$ 7,549	$ 6,973

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders' Equity - USD ($) $ in Thousands	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
Beginning balance at Dec. 31, 2020			$ 217,999	$ 58,335	$ (26,918)	$ (205)	$ 249,211
Net income				7,117			7,117
Other comprehensive income						(144)	(144)
Stock-based compensation expense			135				135
Treasury Stock Purchases					(412)		(412)
Dividends payable on Series D 4.5%, Series G 6%, Series H 3.5%, and Series I 3.0% noncumulative perpetual preferred stock				(283)			(283)
Cash dividends on common stock (per share declared)				(2,281)			(2,281)
Dividend reinvestment plan			111	(111)
Stock Purchase Plan			111				111
Ending balance at Mar. 31, 2021			218,356	62,777	(27,330)	(349)	253,454
Beginning balance at Dec. 31, 2021			222,850	81,171	(31,125)	1,128	274,024
Net income				9,952			9,952
Other comprehensive income						(2,403)	(2,403)
Stock-based compensation expense			95				95
Treasury Stock Purchases					(8)		(8)
Dividends payable on Series D 4.5%, Series G 6%, Series H 3.5%, and Series I 3.0% noncumulative perpetual preferred stock				(276)			(276)
Redemption of Series G Preferred Stock			(5,330)				(5,330)
Issuance of Series I Preferred Stock			2,620				2,620
Cash dividends on common stock (per share declared)				(2,601)			(2,601)
Dividend reinvestment plan			114	(114)
Stock Purchase Plan			86				86
Ending balance at Mar. 31, 2022			$ 220,435	$ 88,132	$ (31,133)	$ (1,275)	$ 276,159

Consolidated Statement of Cha_2

Consolidated Statement of Changes in Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Exercise of stock options (shares)
Cash dividends on common stock (per share)	$ 0.16	$ 0.14
Treasury stock purchases (shares)	515	32,093
Series D Preferred Stock [Member]
Preferred stock, dividend rate	4.50%	4.50%
Series G Preferred Stock [Member]
Preferred stock, dividend rate		6.00%
Series H Preferred Stock [Member]
Preferred stock, dividend rate	3.50%	3.50%
Series I Preferred Stock [Member]
Preferred stock, dividend rate	3.00%

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flows from Operating Activities:
Net Income	$ 9,952	$ 7,117
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation of premises and equipment	629	634
Amortization and accretion, net	(375)	(191)
(Reversal) provision for loan losses	(2,575)	1,865
Deferred income tax expense (benefit)	735	(617)
Loans originated for sale	(2,452)	(10,074)
Proceeds from sale of loans	3,144	12,731
Gain on sales of loans originated for sale	(65)	(274)
Realized and unrealized losses on equity investments	2,685	196
Stock-based compensation expense	95	135
BOLI income	(755)	(701)
(Increase) decrease in accrued interest receivable	(410)	868
(Increase) decrease in other assets	(107)	3,124
Decrease in accrued interest payable	(497)	(656)
Increase in other liabilities	1,748	211
Net Cash Provided by Operating Activities	11,752	14,368
Cash flows from investing activities:
Proceeds from repayments, calls, and maturities on securities	3,068	5,843
Purchases of securities	(7,488)	(757)
Proceeds from sales of securities	1,233
Proceeds from sale of impaired loans		180
Net increase in loans receivable	(87,723)	(2,891)
Purchases of BOLI		(8,500)
Additions to premises and equipment	(38)	(158)
(Purchase) sale of Federal Home Loan Bank of New York stock	(44)	2,404
Net Cash Used In Investing Activities	(90,992)	(3,879)
Cash flows from financing activities:
Net increase in deposits	69,773	86,085
Net proceeds from Federal Home Loan Bank of New York Advances		10,000
Repayments of Federal Home Loan Bank of New York Advances		(68,000)
Purchase of treasury stock	(8)	(412)
Cash dividends paid on common stock	(2,601)	(2,281)
Cash dividends paid on preferred stock	(276)	(283)
Net proceeds from issuance of common stock	86	111
Net proceeds from issuance of preferred stock	2,620
Payments for redemption of preferred stock	(5,330)
Net Cash Provided by Financing Activities	64,264	25,220
Net (Decrease) Increase in Cash and Cash Equivalents	(14,976)	35,709
Cash and Cash Equivalents - Beginning	411,629
Cash and Cash Equivalents - Ending	396,653	296,938
Supplementary Cash Flow Information:
Cash paid during the year for: Income taxes	411	375
Cash paid during the year for: Interest	$ 3,150	$ 5,169

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2022
Basis of Presentation [Abstract]
Basis of Presentation	Note 1 – Basis of Presentation The accompanying unaudited consolidated financial statements include the accounts of BCB Bancorp, Inc. (the “Company”) and the Company’s wholly owned subsidiaries, BCB Community Bank (the “Bank”), BCB Holding Company Investment Corporation, Special Asset REO I, LLC., and Special Asset REO II, LLC. The Company’s business is conducted principally through the Bank. All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Regulation S-X and, therefore, do not necessarily include all information that would be included in audited consolidated financial statements. The information furnished reflects all adjustments that are, in the opinion of management, necessary for a fair presentation of consolidated financial condition and results of operations. All such adjustments are of a normal recurring nature. These results are not necessarily indicative of the results to be expected for the fiscal year ending December 31 , 2022 or any other future period. The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated statement of financial condition and revenues and expenses for the periods then ended. Actual results could differ significantly from those estimates. These unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the year ended December 31, 2021, which are included in the Company’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission. In preparing these consolidated financial statements, the Company evaluated the events and transactions that occurred between December 31, 2021 and the date these consolidated financial statements were issued. Risks and Uncertainties - We are subject to risks and uncertainties as a result of the COVID-19 pandemic. The full fallout from the pandemic and its long-term impact on economies, markets, industries and financial institutions is not known at this time, and it may take years to fully determine COVID-19’s economic impact. The occurrence of events which adversely affect the global, national and regional economies may have a negative impact on our business. Like other financial institutions, our business relies upon the ability and willingness of our customers to transact business with us, including banking, borrowing and other financial transactions. A strong and stable economy at each of the local, federal and global levels is often a critical component of consumer confidence and typically correlates positively with our customers’ ability and willingness to transact certain types of business with us. Local and global events outside of our control which disrupt the New Jersey, New York, United States and/or global economy may therefore negatively impact our business and financial condition. A public health crisis such as the COVID-19 pandemic is no exception, and its adverse health and economic effects may adversely impact our business and financial condition. As of the date of issuance of the condensed consolidated financial statements, the extent to which the COVID-19 pandemic may impact the Company’s financial condition, liquidity, or results of operations is uncertain.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	3 Months Ended
	Mar. 31, 2022
Recent Accounting Pronouncements [Abstract]
Recent Accounting Pronouncements	Note 2 - Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments - Credit Losses ASU 2016-13, and related guidance, requires entities to report “expected” credit losses on financial instruments and other commitments to extend credit rather than the current “incurred loss” model. These expected credit losses for financial assets held at the reporting date are to be based on historical experience, current conditions, and reasonable and supportable forecasts. This ASU will also require enhanced disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. These disclosures include qualitative and quantitative requirements that provide additional information about the amounts recorded in the consolidated financial statements. The amendments are effective for the Company in 2023. The Company has begun evaluating the impact the adoption of ASU 2016-13 will have on its consolidated financial statements and results of operations. The effect of this change cannot be ascertained at this point, and will depend upon factors including asset components, asset quality and market conditions at the adoption date. The Company has created a Current Expected Credit Loss (“CECL”) task group comprised of members of its finance, credit administration, lending, internal audit, loan operations, compliance, and information systems units. The CECL task group has become familiar with the provisions of ASU 2016-13 and is in the process of implementing the new guidance, which includes, but is not limited to: (1) identifying segments and sub-segments within the loan portfolio that have similar risk characteristics; (2) determining the appropriate methodology for each segment; (3) implementing changes that are necessary to its core operating system and interfaces to be able to capture appropriate data requirements; and (4) evaluating qualitative and economic factors to develop appropriate forecasts for integration into the model. The Company is currently evaluating the effect this guidance may have on its operating results and/or financial position, including assessing any potential impact on its capital.

Reclassification

Reclassification	3 Months Ended
	Mar. 31, 2022
Reclassification [Abstract]
Reclassification	Note 3 – Reclassification Certain amounts for the three month period March 31, 2021 have been reclassified to conform to the current period’s presentation. These changes had no effect on the Company’s results of operations or financial position.

Equity Incentive Plans

Equity Incentive Plans	3 Months Ended
	Mar. 31, 2022
Equity Incentive Plans [Abstract]
Equity Incentive Plans	Note 4 – Equity Incentive Plans Equity Incentive Plans The Company, under the plan approved by its shareholders on April 28, 2011 (“2011 Stock Plan”), authorized the issuance of up to 900,000 shares of common stock of the Company pursuant to grants of stock options. Employees and directors of the Company and the Bank were eligible to participate in the 2011 Stock Plan. All stock options were granted in the form of either "incentive" stock options or "non-qualified" stock options. Incentive stock options have certain tax advantages that must comply with the requirements of Section 422 of the Internal Revenue Code. Only employees were permitted to receive incentive stock options. No awards may be granted under this Plan after April 28, 2021. The Company, under the plan approved by its shareholders on April 26, 2018 (“2018 Equity Incentive Plan”), authorized the issuance of up to 1,000,000 shares of common stock of the Company pursuant to grants of stock options and restricted stock units. Employees and directors of the Company and the Bank are eligible to participate in the 2018 Stock Plan. All stock options will be granted in the form of either "incentive" stock options or "non-qualified" stock options. Incentive stock options have certain tax advantages that must comply with the requirements of Section 422 of the Internal Revenue Code. Only employees are permitted to receive incentive stock options. Under the 2018 Equity Incentive Plan, on February 10, 2021, grants of 66,000 options, in aggregate, were declared for members of the Board of Directors of the Bank and the Company which vest over a 5 -year period, commencing on the first anniversary of the grant date. The exercise price was recorded as of close of business on February 10, 2021. On February 10, 2021, awards of 26,400 shares of restricted stock, in aggregate, were declared for members of the Board of Directors of the Bank and the Company, which vest over a 4 -year period, commencing on the anniversary of the award date. On February 19, 2021, an award of 300 shares of restricted stock was declared for an officer of the Bank and the Company, which vests over a 2 -year period, commencing on the anniversary of the award date. Further, on April 26, 2021, grants of 6,800 options, in aggregate, were declared for certain officers of the Bank and the Company, which vest over a 5 -year period commencing on the first anniversary of the grant date. The exercise price was recorded as of close of business on April 26, 2021. On January 12, 2022, awards of 33,000 shares of restricted stock, in aggregate, were declared for members of the Board of Directors of the Bank and the Company, which vest over a 4 -year period, commencing on the anniversary of the award date. Note 4 – Equity Incentive Plans (Continued) The following table presents a summary of the status of the Company’s restricted shares as of March 31, 2022 and 2021. Number of Shares Awarded Weighted Average Grant Date Fair Value Non-vested at January 1, 2022 26,700 $ 12.89 Granted 33,000 16.00 Vested ( 6,750 ) 12.89 Forfeited - - Non-vested at March 31, 2022 52,950 $ 14.83 Number of Shares Awarded Weighted Average Grant Date Fair Value Non-vested at January 1, 2021 22,304 $ 12.46 Granted 26,700 12.89 Vested - - Forfeited - - Non-vested at March 31, 2021 49,004 $ 12.70 Expected future expenses relating to the non-vested restricted shares outstanding as of March 31, 2022 was approximately $ 690,000 over a weighted average period of 3.47 years . The following tables present a summary of the status of the Company’s outstanding stock option awards as of March 31, 2022 and 2021. Number of Option Shares Range of Exercise Prices Weighted Average Exercise Price Outstanding at January 1, 2022 1,194,425 $ 9.02 - 13.68 $ 11.64 Options granted - - - Options exercised - - - Options forfeited - - - Options expired - - - Outstanding at March 31, 2022 1,194,425 $ 9.02 - 13.68 $ 11.64 As of March 31, 2022, stock options which were granted and were exercisable totaled 890,325 . It is Company policy to issue new shares upon share option exercise. Compensation expense for the three months ended March 31, 2022 and March 31, 2021 was $ 45,000 and $ 50,000 , respectively. Expected future compensation expense relating to the 304,000 shares of unvested options outstanding as of March 31, 2022 was $ 534,000 over a weighted average period of 4.31 years.

Net Income per Common Share

Net Income per Common Share	3 Months Ended
	Mar. 31, 2022
Net Income per Common Share [Abstract]
Net Income per Common Share	Note 5 – Net Income per Common Share Basic net income per common share is computed by dividing net income less dividends on preferred stock by the weighted average number of shares of common stock outstanding. The diluted net income per common share is computed by adjusting the weighted average number of shares of common stock outstanding to include the effects of outstanding stock options, if dilutive, using the treasury stock method. Dilution is not applicable in periods of net loss. For the three months ended March 31, 2022 and 2021, the difference in the weighted average number of basic and diluted common shares was due solely to the effects of outstanding stock options. No adjustments to net income were necessary in calculating basic and diluted net income per share. For the three months ended March 31, 2022 and 2021, the weighted average number of outstanding options considered to be anti-dilutive were 0 and 0 , respectively. The following is a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations: For the Three Months Ended March 31, 2022 2021 Income Shares Per Share Income Shares Per Share (Numerator) (Denominator) Amount (Numerator) (Denominator) Amount (In Thousands, except per share data) Net income available to common stockholders $ 9,676 $ 6,834 Basic earnings per share: Income available to common stockholders $ 9,676 16,980 $ 0.57 $ 6,834 17,115 $ 0.40 Effect of dilutive securities: Stock options - 363 - 117 Diluted earnings per share: Income available to common stockholders $ 9,676 17,343 $ 0.56 $ 6,834 17,232 $ 0.40

Securities

Securities	3 Months Ended
	Mar. 31, 2022
Securities [Abstract]
Securities	Note 6 - Securities Equity Securities Equity securities are defined to include (a) preferred, common and other ownership interests in entities including partnerships, joint ventures and limited liability companies and (b) rights to acquire or dispose of ownership interest in entities at fixed or determinable prices. The following is a summary of unrealized and realized gains and losses recognized in net income on equity securities during the three months ended March 31, 2022 and 2021: For the three months ended March 31, (In Thousands) 2022 2021 Net losses recognized during the period on equity securities held at the reporting period $ ( 2,626 ) $ ( 196 ) Net losses recognized during the period on equity securities sold during the period ( 59 ) - Realized and unrealized losses on equity investments during the reporting period $ ( 2,685 ) $ ( 196 ) Note 6 - Securities (continued) Debt Securities Available for Sale The following tables present by maturity the amortized cost, gross unrealized gains and losses on, and fair value of, securities available for sale as of March 31, 2022 and December 31, 2021: March 31, 2022 Gross Gross Amortized Unrealized Unrealized Cost Gains Losses Fair Value (In Thousands) Residential Mortgage-backed securities: Less than one year $ 2,930 $ - $ 115 $ 2,815 More than one to five years 28 - - 28 More than five to ten years 5,817 1 133 5,685 More than ten years 24,983 22 1,101 23,904 Sub-total: 33,758 23 1,349 32,432 Corporate Debt securities: More than five to ten years 49,226 1,104 560 49,770 Sub-total: 49,226 1,104 560 49,770 Municipal obligations: More than ten years 4,078 27 - 4,105 Sub-total: 4,078 27 - 4,105 Total securities $ 87,062 $ 1,154 $ 1,909 $ 86,307 December 31, 2021 Gross Gross Amortized Unrealized Unrealized Cost Gains Losses Fair Value (In Thousands) Residential Mortgage-backed securities: Due within one year $ 2,952 $ - $ 114 $ 2,838 More than one to five years 53 - - 53 More than five to ten years 6,317 165 27 6,455 More than ten years 21,555 298 287 21,566 Sub-total: 30,877 463 428 30,912 Corporate Debt securities: More than five to ten years 47,765 2,465 159 50,071 Sub-total: 47,765 2,465 159 50,071 Municipal obligations: Due after ten years 4,104 99 - 4,203 Sub-total: 4,104 99 - 4,203 Total Debt Securities Available $ 82,746 $ 3,027 $ 587 $ 85,186 Note 6 - Securities (continued) The unrealized losses, categorized by the length of time of continuous loss position, and fair value of related securities available for sale were as follows: 12 Months or Less More than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses (In Thousands) March 31, 2022 Residential mortgage-backed securities $ 24,077 $ 783 $ 5,178 $ 566 $ 29,255 $ 1,349 Corporate Debt securities 17,883 560 - - 17,883 560 $ 41,960 $ 1,343 $ 5,178 $ 566 $ 47,138 $ 1,909 December 31, 2021 Residential mortgage-backed securities $ 7,801 $ 159 $ 4,681 $ 269 $ 12,482 $ 428 Corporate Debt Securities 12,324 159 - - 12,324 159 $ 20,125 $ 318 $ 4,681 $ 269 $ 24,806 $ 587 Management evaluates securities for other-than-temporary impairment (“OTTI”) at least on a quarterly basis, and more frequently when economic or market conditions warrant such evaluation. Consideration is given to (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer, and (3) whether the Company intends to sell the security or more likely than not will be required to sell the security before its anticipated recovery. At March 31, 2022 and December 31, 2021, management performed an assessment for possible OTTI of the Company’s residential mortgage-backed securities and corporate debt on an issue-by-issue basis, relying on information obtained from various sources, including publicly available financial data, ratings by external agencies, brokers and other sources. The extent of individual analysis applied to each security depended on the size of the Company’s investment, as well as management’s perception of the credit risk associated with each security. Based on the results of the assessment, management believes impairment of these securities, at March 31, 2022 and December 31, 2021, to be temporary.

Loans Receivable and Allowance

Loans Receivable and Allowance for Loan Losses	3 Months Ended
	Mar. 31, 2022
Loans Receivable and Allowance for Loan Losses [Abstract]
Loans Receivable and Allowance for Loan Losses	Note 7 - Loans Receivable and Allowance for Loan Losses The following tables present the recorded investment in loans receivable as of March 31, 2022 and December 31, 2021 by segment and class: March 31, 2022 December 31, 2021 (In Thousands) Residential one-to-four family $ 233,251 $ 224,534 Commercial and multi-family 1,804,815 1,720,174 Construction 141,082 153,904 Commercial business (1) 198,216 191,139 Home equity (2) 52,279 50,469 Consumer 2,726 3,717 2,432,369 2,343,937 Less: Deferred loan fees, net ( 2,459 ) ( 1,876 ) Allowance for loan losses ( 33,980 ) ( 37,119 ) Total Loans, net $ 2,395,930 $ 2,304,942 (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 – Loans Receivable and Allowance for Loan Losses (Continued) Allowance for Loan Losses The allowance for loan loss is evaluated regularly by management and reflects consideration of all significant factors that affect the collectability of the loan portfolio. The Company’s methodology for assessing the adequacy of the allowance for loan losses consists of several key elements. These elements include a general allocated reserve for performing loans, a specific reserve for impaired loans and an unallocated portion. The Company consistently applies the following comprehensive methodology. During the quarterly review of the allowance for loan losses, the Company considers a variety of qualitative factors that include:  Lending policies and procedures;  Personnel responsible for the particular portfolio - relative to experience and ability of staff;  Trend for past due, criticized and classified loans;  Relevant economic factors;  Quality of the loan review system;  Value of collateral for collateral dependent loans;  The effect of any concentrations of credit and the changes in the level of such concentrations; and  Other external factors. The methodology includes the segregation of the loan portfolio into two divisions: performing loans and loans determined to be impaired. Loans which are performing are evaluated homogeneously by loan class or loan type. The allowance for performing loans is evaluated based on historical loan loss experience with an adjustment for the qualitative factors listed above. Impaired loans can be loans which are more than 90 days delinquent, troubled debt restructurings, in the process of foreclosure, or a forced bankruptcy plan. These loans are individually evaluated for loan loss either by current appraisal, or net present value of expected cash flows. Management reviews the overall estimate for feasibility and bases the loan loss provision accordingly. During 2022 and 2021, additional stress tests were performed to model a potential collateral deficiency on those loans that are in sectors that have demonstrated a weakness in the current COVID environment. These stress tests supported an additional allowance by estimating probable losses for loans in sectors that are specifically challenged in the pandemic condition. The Bank also maintains an unallocated allowance to cover uncertainties that could affect management’s estimate of probable losses. The unallocated component of the allowance reflects the margin of imprecision inherent in the underlying assumptions used in the methodologies for estimating allocated and general reserves in the portfolio. Management must make estimates using assumptions and information that is often subjective and subject to change. The loan portfolio is segmented into the following loan segments, where the risk level for each class is analyzed when determining the allowance for loan losses: Residential one-to-four family real estate loans involve certain risks such as interest rate risk and risk of non-repayment. Adjustable-rate residential real estate loans decrease the interest rate risk to the Bank that is associated with changes in interest rates but involve other risks, primarily because as interest rates rise, the payment by the borrower rises to the extent permitted by the terms of the loan, thereby increasing the potential for default. At the same time, the marketability of the underlying properties may be adversely affected by higher interest rates. Repayment risk may be affected by a number of factors including, but not necessarily limited to, job loss, divorce, illness and personal bankruptcy of the borrower. Commercial and multi-family real estate lending entails additional risks as compared with residential family property lending. Such loans typically involve large loan balances to single borrowers or groups of related borrowers. The payment experience on such loans is typically dependent on the successful operation of the real estate project. The success of such projects is sensitive to changes in supply and demand conditions in the market for commercial real estate as well as general economic conditions. Construction lending is generally considered to involve a high risk due to the concentration of principal in a limited number of loans and borrowers and the effects of the general economic conditions on developers and builders. Moreover, a construction loan can involve additional risks because of the inherent difficulty in estimating both a property’s value at completion of the project and the estimated cost (including interest) of the project. The nature of these loans is such that they are generally difficult to evaluate and monitor. In addition, speculative construction loans to a builder are not necessarily pre-sold and thus pose a greater potential risk to the Bank than construction loans to individuals on their personal residence. Commercial business lending, including lines of credit, is generally considered higher risk due to the concentration of principal in a limited number of loans and borrowers and the effects of general economic conditions on the business. Commercial business loans are primarily secured by inventories and other business assets. In many cases, any repossessed collateral for a defaulted commercial business loans will not provide an adequate source of repayment of the outstanding loan balance. Home equity lending entails certain risks such as interest rate risk and risk of non-repayment. The marketability of the underlying property may be adversely affected by higher interest rates, decreasing the collateral value securing the loan. Repayment risk can be affected by job loss, divorce, illness and personal bankruptcy of the borrower. Home equity line of credit lending entails securing an equity interest in the borrower’s home. In many cases, the Bank’s position in these loans is as a junior lien holder to another institution’s superior lien. This type of lending is often priced on an adjustable rate basis with the rate set at or above a predefined index. Adjustable-rate loans decrease the interest rate risk to the Bank that is associated with changes in interest rates but involve other risks, primarily because as interest rates rise, the payment by the borrower rises to the extent permitted by the terms of the loan, thereby increasing the potential for default. Other consumer loans generally have more credit risk because of the type and nature of the collateral and, in certain cases, the absence of collateral. Consumer loans generally have shorter terms and higher interest rates than other lending. In addition, consumer lending collections are dependent on the borrower’s continuing financial stability, and thus are more likely to be adversely affected by job loss, divorce, illness and personal bankruptcy. In many cases, any repossessed collateral for a defaulted consumer loan will not provide an adequate source of repayment of the outstanding loan. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) The following table sets forth the activity in the Company’s allowance for loan losses for the three months ended March 31, 2022, and the related portion of the allowances for loan losses that is allocated to each loan class, as of March 31, 2022 (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for credit losses: Beginning Balance, January 1, 2022 $ 4,094 $ 22,065 $ 2,231 $ 8,000 $ 533 $ 14 182 $ 37,119 Charge-offs: - - - ( 766 ) - - - ( 766 ) Recoveries: - - - 1 3 198 - 202 (Reversals) provisions: ( 1,593 ) ( 1,245 ) ( 266 ) 901 ( 202 ) ( 197 ) 27 ( 2,575 ) Ending Balance, March 31, 2022 2,501 20,820 1,965 8,136 334 15 209 33,980 Ending Balance attributable to loans: Individually evaluated for impairment 221 618 295 6,000 10 - - 7,144 Collectively evaluated for impairment 2,280 20,202 1,670 2,136 324 15 209 26,836 Ending Balance, March 31, 2022 2,501 20,820 1,965 8,136 334 15 209 33,980 Loans Receivables: Individually evaluated for impairment 4,836 24,901 2,954 7,517 747 - - 40,955 Collectively evaluated for impairment 228,415 1,779,914 138,128 190,699 51,532 2,726 - 2,391,414 Total Gross Loans: $ 233,251 $ 1,804,815 $ 141,082 $ 198,216 $ 52,279 $ 2,726 $ - $ 2,432,369 _____________________________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table sets forth the activity in the Company’s allowance for loan losses for the three months ended March 31, 2021 (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for credit losses: Beginning Balance, January 1, 2021 $ 3,293 $ 21,772 $ 1,977 $ 6,306 $ 286 $ - $ 5 $ 33,639 Charge-offs: ( 57 ) - - - - - - ( 57 ) Recoveries: 27 - - - 3 - - 30 (Reversals) provisions: ( 426 ) 1,347 25 275 4 - 640 1,865 Ending Balance, March 31, 2021 $ 2,837 $ 23,119 $ 2,002 $ 6,581 $ 293 $ - $ 645 $ 35,477 Ending Balance attributable to loans: Individually evaluated for impairment 302 381 - 4,601 23 - - 5,307 Collectively evaluated for impairment 2,535 22,738 2,002 1,980 270 - 645 30,170 Ending Balance, March 31, 2021 2,837 23,119 2,002 6,581 293 - 645 35,477 Loans Receivables: Individually evaluated for impairment 5,509 44,086 2,787 13,269 1,693 - - 67,344 Collectively evaluated for impairment 228,866 1,656,027 164,437 164,071 51,667 851 - 2,265,919 Total Gross Loans: 234,375 1,700,113 167,224 177,340 53,360 851 - 2,333,263 _____________________________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) The following table sets forth the amount recorded in loans receivable at December 31, 2021. The table also details the amount of total loans receivable that are evaluated individually, and collectively, for impairment and the related portion of the allowance for loan losses that is allocated to each loan class (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for credit losses: Ending Balance attributable to loans: Individually evaluated for impairment $ 265 $ 1,690 $ 210 $ 5,650 $ 13 $ - $ - $ 7,828 Collectively evaluated for impairment 3,829 20,375 2,021 2,350 520 14 182 29,291 Ending Balance, December 31, 2021 $ 4,094 $ 22,065 $ 2,231 $ 8,000 $ 533 $ 14 $ 182 $ 37,119 Loans Receivables: Individually evaluated for impairment $ 4,961 $ 31,745 $ 2,847 $ 8,746 $ 1,083 $ - $ - $ 49,382 Collectively evaluated for impairment 219,573 1,688,429 151,057 182,393 49,386 3,717 - 2,294,555 Total Gross Loans: $ 224,534 $ 1,720,174 $ 153,904 $ 191,139 $ 50,469 $ 3,717 $ - $ 2,343,937 (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) The following table summarizes the average recorded investment and interest income recognized on impaired loans with no related allowance recorded by portfolio class for the three months ended March 31, 2022 and 2021 (in thousands): Three Months Ended March 31, 2022 2022 2021 2021 Average Interest Average Interest Recorded Income Recorded Income Investment Recognized Investment Recognized Loans with no related allowance recorded: Residential one-to-four family $ 2,935 $ 37 $ 3,453 $ 34 Commercial and Multi-family 21,220 263 44,958 282 Construction - - 1,394 36 Commercial business (1) 1,952 65 5,171 13 Home equity (2) 613 5 1,196 10 Consumer - - - - Total Impaired Loans with no allowance recorded: $ 26,720 $ 370 $ 56,172 $ 375 Loans with an allowance recorded: Residential one-to-four family $ 1,964 $ - $ 2,943 $ 32 Commercial and Multi-family 7,103 - 8,013 129 Construction 2,901 2 - - Commercial business (1) 6,180 9 7,710 93 Home equity (2) 303 - 438 2 Consumer - - - - Total Impaired Loans with an allowance recorded: $ 18,451 $ 11 $ 19,104 $ 256 Total Impaired Loans: $ 45,171 $ 381 $ 75,276 $ 631 __________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table summarizes the recorded investment by portfolio class at March 31, 2022 and December 31, 2021. (in thousands): As of March 31, 2022 As of December 31, 2021 Recorded Unpaid Principal Related Recorded Unpaid Principal Related Investment Balance Allowance Investment Balance Allowance Loans with no related allowance recorded: Residential one-to-four family $ 2,920 $ 3,272 $ - $ 2,950 $ 3,300 $ - Commercial and multi-family 21,525 22,832 - 20,915 22,100 - Construction - - - - - - Commercial business (1) 1,790 5,783 - 2,114 6,905 - Home equity (2) 446 446 - 779 780 - Total Impaired Loans with no related allowance recorded: $ 26,681 $ 32,333 $ - $ 26,758 $ 33,085 $ - Loans with an allowance recorded: Residential one-to-four family $ 1,916 $ 1,937 $ 221 $ 2,011 $ 2,032 $ 265 Commercial and Multi-family 3,376 6,930 618 10,830 14,494 1,690 Construction 2,954 2,954 295 2,847 2,847 210 Commercial business (1) 5,727 16,529 6,000 6,632 17,514 5,650 Home equity (2) 301 301 10 304 304 13 Total Impaired Loans with an allowance recorded: $ 14,274 $ 28,651 $ 7,144 $ 22,624 $ 37,191 $ 7,828 Total Impaired Loans: $ 40,955 $ 60,984 $ 7,144 $ 49,382 $ 70,276 $ 7,828 __________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) A troubled debt restructured loan (“TDR”) is a loan that has been modified whereby the Company has agreed to make certain concessions to a borrower to meet the needs of both the borrower and the Company to maximize the ultimate recovery of a loan. A TDR occurs when a borrower is experiencing, or is expected to experience, financial difficulties and the loan is modified using a concession that would otherwise not be granted to the borrower. All TDRs were considered impaired and therefore were individually evaluated for impairment in the calculation of the allowance for loan losses. Prior to their classification as TDRs, certain of these loans had been collectively evaluated for impairment in the calculation of the allowance for loan losses. At March 31, 2022 At December 31, 2021 (In thousands) Recorded investment in TDRs: Accrual status $ 14,659 $ 12,402 Non-accrual status 390 3,570 Total recorded investment in TDRs $ 15,049 $ 15,972 The Company originated one TDR loan totaling $ 115,388 and one TDR loan totaling $ 96,532 for the three-months ended March 31, 2022 and March 31, 2021, respectively. For the three-months ended March 31, 2022 and March 31, 2021, TDRs, for which there was a payment default within twelve months of restructuring, totaled $ 0 and $ 127,449 for one loan, respectively. The following table sets forth the delinquency status of total loans receivable as of March 31, 2022: Loans Receivable 30-59 Days 60-90 Days Greater Than Total Past Total Loans >90 Days Past Due Past Due 90 Days Due Current Receivable and Accruing (In Thousands) Residential one-to-four family $ 327 $ - $ 86 $ 413 $ 232,838 $ 233,251 $ - Commercial and multi-family 1,983 - 757 2,740 1,802,075 1,804,815 - Construction - - 2,954 2,954 138,128 141,082 - Commercial business (1) 3,623 4 2,932 6,559 191,657 198,216 - Home equity (2) 188 - - 188 52,091 52,279 - Consumer - - - - 2,726 2,726 - Total $ 6,121 $ 4 $ 6,729 $ 12,854 $ 2,419,515 $ 2,432,369 $ - _________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table sets forth the delinquency status of total loans receivable at December 31, 2021: Loans Receivable 30-59 Days 60-90 Days Greater Than Total Past Total Loans >90 Days Past Due Past Due 90 Days Due Current Receivable and Accruing (In Thousands) Residential one-to-four family $ 1,063 $ - $ 86 $ 1,149 $ 223,385 $ 224,534 $ - Commercial and multi-family 1,181 - 5,167 6,348 1,713,826 1,720,174 - Construction 2,899 - 2,847 5,746 148,158 153,904 - Commercial business (1) 405 166 6,775 7,346 183,793 191,139 3,124 Home equity (2) 190 - 27 217 50,252 50,469 - Consumer - - - - 3,717 3,717 - Total $ 5,738 $ 166 $ 14,902 $ 20,806 $ 2,323,131 $ 2,343,937 $ 3,124 (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) The table below sets forth the amounts and types of non-accrual loans in the Bank’s loan portfolio at March 31, 2022 and December 31, 2021, respectively. Loans are placed on non-accrual status when they become more than 90 days delinquent, or when the collection of principal and/or interest become doubtful. As of March 31, 2022, and December 31, 2021, non-accrual loans differed from the amount of total loans past due greater than 90 days due to troubled debt restructuring of loans, loans 90 days past due and still accruing, or loans that were previously 90 days past due which are maintained on non-accrual status for a minimum of six months until the borrower has demonstrated its ability to satisfy the terms of the loan. There were $ 3.3 million at March 31, 2022 and $ 3.8 million at December 31, 2021 in nonaccrual loans that were less than ninety days past due. Nonaccrual loans do not include loans acquired with deteriorated credit quality which were recorded at their fair value at acquisition and totaled $ 665,000 at March 31, 2022 and $ 668,000 at December 31, 2021. As of March 31, 2022 As of December 31, 2021 (In Thousands) (In Thousands) Non-Accruing Loans: Residential one-to-four family $ 278 $ 282 Commercial and multi-family 757 8,601 Construction 2,954 2,847 Commercial business (1) 5,243 3,132 Home equity (2) - 27 Total $ 9,232 $ 14,889 _________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. Had non-accrual loans been performing in accordance with their original terms, the interest income recognized for the three months ended March 31, 2022 and the twelve months ended December 31, 2021 would have been approximately $ 246,000 and $ 1.3 million, respectively. The Bank has not committed to lend additional funds to the borrowers whose loans have been placed on nonaccrual status. At March 31, 2022 and December 31, 2021 there were $ 0 and $ 3.1 million, respectively, of loans which were more than ninety days past due and still accruing interest. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) Criticized and Classified Assets Company policies provide for a classification system for problem assets. Under this classification system, problem assets are classified as “substandard,” “doubtful,” or “loss.” When the Company classifies problem assets, the Company may establish general allowances for loan losses in an amount deemed prudent by management. General allowances represent loss allowances which have been established to recognize the inherent risk associated with lending activities, but which, unlike specific allowances, have not been allocated to particular problem assets. A portion of general loss allowances established to cover possible losses related to assets classified as substandard or doubtful may be included in determining our regulatory capital. Specific valuation allowances for loan losses generally do not qualify as regulatory capital. The loans classified as substandard are secured either by residential real estate, commercial real estate or heavy equipment. The loans that have been classified substandard were classified as such primarily due to payment status, because updated financial information has not been timely provided, or the collateral underlying the loan is in the process of being revalued. The Company’s internal credit risk grades are based on the definitions currently utilized by the banking regulatory agencies. The grades assigned and definitions are as follows, and loans graded excellent, above average, good and watch list (risk ratings 1-5) are treated as “pass” for grading purposes. The “criticized” risk rating (6) and the “classified” risk ratings (7-9) are detailed below: 6 – Special Mention- Loans currently performing but with potential weaknesses including adverse trends in borrower’s operations, credit quality, financial strength, or possible collateral deficiency. 7 – Substandard - Loans that are inadequately protected by current sound worth, paying capacity, and collateral support. Loans on “nonaccrual” status. The loan needs special and corrective attention. 8 – Doubtful - Weaknesses in credit quality and collateral support make full collection improbable, but pending reasonable factors remain sufficient to defer the loss status. 9 – Loss - Continuance as a bankable asset is not warranted. However, this does not preclude future attempts at partial recovery. The following table presents the loan portfolio types summarized by the aggregate pass rating and the classified ratings of special mention and substandard within the Company’s internal risk rating system as of March 31, 2022 (in thousands). As of March 31, 2022, the Company had no loans with the classified rating of doubtful or loss. Pass Special Mention Substandard Total Residential one-to-four family $ 232,476 $ 498 $ 277 $ 233,251 Commercial and multi-family 1,741,596 43,908 19,311 1,804,815 Construction 138,128 - 2,954 141,082 Commercial business (1) 186,148 4,972 7,096 198,216 Home equity (2) 52,067 - 212 52,279 Consumer 2,726 - - 2,726 Total Gross Loans $ 2,353,141 $ 49,378 $ 29,850 $ 2,432,369 _________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table presents the loan portfolio types summarized by the aggregate pass rating and the classified ratings of special mention and substandard within the Company’s internal risk rating system as of December 31, 2021 (in thousands). As of December 31, 2021, the Company had no loans with the classified rating of doubtful or loss. Pass Special Mention Substandard Total Residential one-to-four family $ 223,660 $ 505 $ 369 $ 224,534 Commercial and multi-family 1,647,701 45,087 27,386 1,720,174 Construction 151,057 - 2,847 153,904 Commercial business (1) 178,056 4,767 8,316 191,139 Home equity (2) 50,230 - 239 50,469 Consumer 3,717 - - 3,717 Total Gross Loans $ 2,254,421 $ 50,359 $ 39,157 $ 2,343,937 ________ (1) Includes business lines of credit. (2) Includes home equity lines of credit.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2022
Stockholders' Equity [Abstract]
Stockholders' Equity	Note 8 – Stockholders’ Equity On March 24, 2022, BCB Bancorp, Inc. (the “Company”) closed a round of private placement of Series I Noncumulative Perpetual Stock, par value $ 0.01 per share (the “Series I Preferred Stock”), resulting in gross proceeds of $ 2,620,000 for 260 shares. On February 4, 2022, the Company redeemed all 533 outstanding shares of its Series G 6.0 % Noncumulative Perpetual Preferred Stock, at their face value of $ 10,000 per share, for a total redemption amount of $ 5.3 million. On December 21, 2021, BCB Bancorp, Inc. (the “Company”) closed a round of private placement of Series I Noncumulative Perpetual Stock, par value $ 0.01 per share (the “Series I Preferred Stock”), resulting in gross proceeds of $ 3,200,000 for 320 shares.

Bank Owned Life Insurance

Bank Owned Life Insurance	3 Months Ended
	Mar. 31, 2022
Bank Owned Life Insurance [Abstract]
Bank Owned Life Insurance	Note 9 – Bank Owned Life Insurance The Bank purchased an additional $ 8.5 million of bank owned life insurance (“BOLI”) in January, 2021. BOLI involves life insurance purchased by the Bank on a chosen group of employees, and the Bank is owner and beneficiary of the policies. At March 31, 2022 the Bank had $ 73.2 million in BOLI. BOLI is accounted for using the cash surrender value method and is recorded at its net realizable value.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	3 Months Ended
	Mar. 31, 2022
Goodwill and Other Intangible Assets [Abstract]
Goodwill and Other Intangible Assets	Note 10 – Goodwill and Other Intangible Assets The Company’s intangible assets consist of goodwill and core deposit intangibles in connection with the acquisition of IA Bancorp, Inc. as of April 17, 2018. The initial recording of goodwill and other intangible assets requires subjective judgments concerning estimates of the fair value of the acquired assets and assumed liabilities. Goodwill is not amortized but is subject to annual tests for impairment or more often if events or circumstances indicate it may be impaired. The Company’s core deposit intangibles are amortized on an accelerated basis using an estimated life of 10 years and in accordance with U.S. GAAP are evaluated annually for impairment. An impairment loss will be recognized if the carrying amount of the intangible asset is not recoverable and exceeds fair value. The carrying amount of the intangible asset is not considered recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use of the asset. The Company believes that the fair values of our goodwill and other intangible assets were in excess of their carrying amounts and there was no impairment at March 31, 2022. Amortization expense of the core deposit intangibles was $ 14,000 and $ 16,000 for the three months ended March 31, 2022 and 2021, respectively. The unamortized balance of the core deposit intangibles and the amount of goodwill at March 31, 2022 was $ 164,000 and $ 5.2 million, respectively. The unamortized balance of the core deposits intangibles and the amount of goodwill at December 31, 2021 was $ 178,000 and $ 5.2 million, respectively.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2022
Fair Value of Financial Instruments [Abstract]
Fair Value of Financial Instruments	Note 11 – Fair Values of Financial Instruments Guidance on fair value measurements establishes a fair value hierarchy that prioritizes the inputs to valuation methods used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: Level 1 : Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 : Quoted prices in markets that are not active, or inputs that are observable either directly or indirectly, for substantially the full term of the asset or liability. Level 3 : Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported with little or no market activity). An asset or liability’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets that the Company measured at fair value on a recurring basis were as follows (In thousands): (Level 1) (Level 2) Quoted Prices in Significant (Level 3) Active Markets Other Significant for Identical Observable Unobservable Description Total Assets Inputs Inputs As of March 31, 2022: Securities Debt Securities Available for Sale $ 86,307 $ - $ 86,307 $ - Marketable Equities $ 21,269 $ 21,269 $ - $ - Total Securities $ 107,576 $ 21,269 $ 86,307 $ - As of December 31, 2021: Securities Debt Securities Available for Sale $ 85,186 $ - $ 85,186 $ - Marketable Equities $ 25,187 $ 25,187 $ - $ - Total Securities $ 110,373 $ 25,187 $ 85,186 $ - The Company’s policy is to recognize transfers between levels as of the actual date of the event or change in circumstances that caused the transfer. There were no transfers of assets or liabilities into or out of Level 1, Level 2, or Level 3 of the fair value hierarchy during the three months ended March 31, 2022 and 2021. There were no liabilities measured at fair value on a recurring basis at March 31, 2022 or December 31, 2021. Note 11 – Fair Values of Financial Instruments (Continued) Assets that the Company measured at fair value on a nonrecurring basis were as follows. (In thousands): (Level 1) (Level 2) Quoted Prices in Significant (Level 3) Active Markets Other Significant for Identical Observable Unobservable Description Total Assets Inputs Inputs As of March 31, 2022 Impaired Loans $ 7,130 $ - $ - $ 7,130 Other real estate owned $ 75 $ - $ - $ 75 As of December 31, 2021: Impaired Loans $ 14,796 $ - $ - $ 14,796 Other real estate owned $ 75 $ - $ - $ 75 There were no liabilities measured at fair value on a nonrecurring basis at March 31, 2022 or December 31, 2021. Note 11 – Fair Values of Financial Instruments (Continued) The following tables present additional quantitative information as of March 31, 2022 and December 31, 2021 about assets measured at fair value on a nonrecurring basis and for which the Company has utilized adjusted Level 3 inputs to determine fair value. (Dollars in thousands): Quantitative Information about Level 3 Fair Value Measurements Fair Value Valuation Unobservable Estimate Techniques Input Range March 31, 2022: Impaired Loans $ 7,130 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Other real estate owned $ 75 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Fair Value Valuation Unobservable Estimate Techniques Input Range December 31, 2021: Impaired Loans $ 14,796 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Other real estate owned $ 75 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % (1) Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various level 3 inputs which are not objectively determinable. (2) Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The range of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal. The following information should not be interpreted as an estimate of the fair value of the entire Company since a fair value calculation is only provided for a limited portion of the Company’s assets and liabilities. Due to a wide range of valuation techniques and the degree of subjectivity used in making the estimates, comparisons between the Company’s disclosures and those of other companies may not be meaningful. The following methods and assumptions were used to estimate the fair values of the Company’s financial instruments as of March 31, 2022 and December 31, 2021. Cash and Cash Equivalents and Interest-Earning Time Deposits (Carried at Cost) The carrying amounts reported in the consolidated statements of financial condition for cash and short-term instruments approximate fair values. Securities (Carried at Fair Value) The fair value of securities is determined by obtaining quoted market prices on nationally recognized security exchanges (Level 1) or, by matrix pricing (Level 2), which is a mathematical technique used widely in the industry to value debt securities without relying exclusively on quoted market prices for the specific securities but rather by relying on the securities’ relationship to other benchmark quoted prices. Loans Held for Sale (Carried at Cost) The fair value of loans held for sale is determined, when possible, using quoted secondary-market prices. If no such quoted prices exist, the fair value of a loan is determined using quoted prices for a similar loan or loans, adjusted for specific attributes of that loan. Loans held for sale are carried at the lower of cost or fair value. Loans Receivable (Carried at Cost) The fair values of loans, except for certain impaired loans, are estimated using discounted cash flow analyses, using market rates at the date of the Statement of Financial Condition that reflect the credit and interest rate-risk inherent in the loans. Projected future cash flows are calculated based upon contractual maturity or call dates, projected repayments and prepayments of principal. Generally, for variable rate loans that reprice frequently and with no significant change in credit risk, fair values are based on carrying values. Note 11 – Fair Values of Financial Instruments (Continued) Impaired Loans (Generally Carried at Fair Value) Impaired loans are those for which the Company has measured and recorded an impairment generally based on the fair value of the loan’s collateral, less estimated costs to sell. Fair value is generally determined based upon independent third-party appraisals of the properties, or discounted cash flows based upon the expected proceeds. These assets are included as Level 3 fair values, based upon the lowest level of input that is significant to the fair value measurements. The fair value at March 31, 2022 and December 31, 2021 consisted of the loan balances of $ 14.3 million net of a valuation allowance of $ 7.1 million and $ 22.6 million net of a valuation of loan allowance of $ 7.8 million, respectively. Other Real Estate Owned (Generally Carried at Lower of Cost or Fair Value) Real Estate Owned is generally carried at fair value less estimated costs to sell which is determined based upon independent third-party appraisals of the properties or based upon the expected proceeds from a pending sale. These assets are included as Level 3 fair values, based upon the lowest level of input that is significant to the fair value measurements. FHLB of New York Stock (Carried at Cost) The carrying amount of restricted investment in bank stock approximates fair value and considers the limited marketability of such securities. Accrued Interest Receivable and Payable (Carried at Cost) The carrying amount of accrued interest receivable and accrued interest payable approximates its fair value. Deposits (Carried at Cost) The fair values disclosed for demand deposits (e.g., interest and non-interest checking, passbook savings and money market accounts1) are, by definition, equal to the amount payable on demand at the reporting date (i.e., their carrying amounts). Fair values for fixed-rate certificates of deposit are estimated using a discounted cash flow calculation that applies interest rates currently being offered in the market on certificates to a schedule of aggregated expected monthly maturities on time deposits. Debt Including Subordinated Debentures (Carried at Cost) Fair values of debt are estimated using discounted cash flow analysis, based on quoted prices for new long-term debt with similar credit risk characteristics, terms and remaining maturity. Prices obtained from this active market represent a market value that is deemed to represent the transfer price if the liability were assumed by a third party. Off-Balance Sheet Financial Instruments (Disclosed at Cost) Fair values for the Company’s off-balance sheet financial instruments (lending commitments and unused lines of credit) are based on fees currently charged in the market to enter into similar agreements, taking into account, the remaining terms of the agreements and the counterparties’ credit standing. The fair value of these commitments was deemed immaterial and is not presented in the accompanying table. Note 11 – Fair Values of Financial Instruments (Continued) The carrying values and estimated fair values of financial instruments were as follows as of March 31, 2022 and December 31, 2021: As of March 31, 2022 Quoted Prices in Active Significant Significant Carrying Markets for Identical Assets Other Observable Inputs Unobservable Inputs Value Fair Value (Level 1) (Level 2) (Level 3) (In Thousands) Financial assets: Cash and cash equivalents $ 396,653 $ 396,653 $ 396,653 $ - $ - Interest-earning time deposits 735 735 - 735 - Debt securities available for sale 86,307 86,307 - 86,307 - Equity investments 21,269 21,269 21,269 - - Loans held for sale 325 325 - 325 - Loans receivable, net 2,395,930 2,333,896 - - 2,333,896 FHLB of New York stock, at cost 6,128 6,128 - 6,128 - Accrued interest receivable 9,593 9,593 - 9,593 - Financial liabilities: Deposits 2,631,175 2,532,283 1,949,169 583,114 - Borrowings 71,848 68,572 - 68,572 - Subordinated debentures 37,333 43,354 - 43,354 - Accrued interest payable 553 553 - 553 - As of December 31, 2021 Quoted Prices in Active Significant Significant Carrying Markets for Identical Assets Other Observable Inputs Unobservable Inputs Value Fair Value (Level 1) (Level 2) (Level 3) (In Thousands) Financial assets: Cash and cash equivalents $ 411,629 $ 411,629 $ 411,629 $ - $ - Interest-earning time deposits 735 735 - 735 - Debt securities available for sale 85,186 85,186 - 85,186 - Equity investments 25,187 25,187 25,187 - - Loans held for sale 952 952 - 952 - Loans receivable, net 2,304,942 2,313,204 - - 2,313,204 FHLB of New York stock, at cost 6,084 6,084 - 6,084 - Accrued interest receivable 9,183 9,183 - 9,183 - Financial liabilities: Deposits 2,561,402 2,520,191 1,881,121 639,070 - Debt 71,711 71,214 - 71,214 - Subordinated debentures 37,275 45,020 - 45,020 - Accrued interest payable 1,051 1,051 - 1,051 -

Subordinated Debt

Subordinated Debt	3 Months Ended
	Mar. 31, 2022
Subordinated Debt [Abstract]
Subordinated Debt	Note 12 – Subordinated debt On July 30, 2018, the Company issued $ 33.5 million of fixed-to-floating rate subordinated debentures (the “Notes”) in a private placement. The Notes have a 10 -year term and bear interest at a fixed annual rate of 5.625 % for the first five years of the term (the "Fixed Interest Rate Period"). From and including August 1, 2023, the interest rate will adjust to a floating rate based on the three-month LIBOR plus 2.72 % until redemption or maturity (the "Floating Interest Rate Period"). The Notes are scheduled to mature on August 1, 2028. Subject to limited exceptions, the Company cannot redeem the Notes for the first five years of the term. The Company will pay interest in arrears semi-annually during the Fixed Interest Rate Period and quarterly during the Floating Interest Rate Period during the term of the Notes. The Notes constitute an unsecured and subordinated obligation of the Company and rank junior in right of payment to any senior indebtedness and obligations to general and secured creditors. The Notes qualify as Tier 2 capital for the Company for regulatory purposes, when applicable, and the portion that the Company contributes to the Bank will qualify as Tier 1 capital for the Bank. The additional capital is used for general corporate purposes including organic growth initiatives. Subordinated debt includes associated deferred costs of $ 291,000 and $ 349,000 at March 31, 2022 and December 31, 2021, respectively. The Company also has $ 4,124,000 of mandatory redeemable trust preferred securities. The interest rate on these floating rate junior subordinated debentures adjusts quarterly, equal to the three-month LIBOR plus 2.65 %. As it is anticipated that LIBOR would not be supported in its current form after June 30, 2023, the Company is reviewing the agreements for the above debentures to determine alternative reference rates and does not anticipate there will be a significant financial statement impact.

Lease Obligations

Lease Obligations	3 Months Ended
	Mar. 31, 2022
Lease Obligations [Abstract]
Lease Obligations	Note 13 – Lease Obligations The Company leases 28 of its offices under various operating lease agreements. The leases have remaining terms of one year to 10 years. The leases contain provisions for the payment by the Company of its pro-rata share of real estate taxes, insurance, common area maintenance and other variable expenses. The Company will allocate payments made under such leases between lease and non-lease components. Some leases contain renewal options and options to purchase the assets. The Company has elected not to recognize a lease liability and a right of use asset for leases with a lease term of 12 or fewer months. The following tables present certain information related to the Company’s leases (in thousands): Three Months Ended March 31, 2022 Three Months Ended March 31, 2021 Operating lease cost $ 902 $ 952 Variable lease cost-operating leases $ 218 $ 246 At March 31, 2022 At December 31, 2021 Supplemental balance sheet information related to leases: Operating Leases Operating lease right-of-use assets $ 11,883 $ 12,457 Current liabilities $ 3,123 $ 3,296 Operating lease liabilities (noncurrent portion) 10,057 10,529 Imputed Interest ( 1,000 ) ( 1,073 ) Total operating lease liabilities $ 12,180 $ 12,752 The weighted average remaining lease term for operating leases at March 31, 2022 and December 31, 2021 was 5.86 years and 5.99 years, respectively. The weighted average discount rate for operating leases at March 31, 2022 and December 31, 2021 was 2.58 percent and 2.60 percent, respectively. The following table summarizes the Company’s maturity of lease obligations for operating leases at March 31, 2022 and December 31, 2021 (in thousands): Maturities of lease liabilities: At March 31, 2022 At December 31, 2021 Operating Leases Operating Leases One year or less $ 3,123 $ 3,296 Over one year through three years 4,322 4,455 Over three years through five years 2,986 3,012 Over five years 2,749 3,062 Gross Operating Lease Liabilities $ 13,180 $ 13,825 Imputed Expenses ( 1,000 ) ( 1,073 ) Total Operating Lease Liabilities $ 12,180 $ 12,752

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 14 – Subsequent Events On April 13, 2022 , the Board of Directors of the Company declared a cash dividend of $ 0.16 per share to shareholders of record of its common stock on May 2, 2022 with a payment date of May 16, 2022 . On May 1, 2022, the Company redeemed all 940 outstanding shares of its Series D 4.5 % Noncumulative Perpetual Preferred Stock, at their face value of $ 10,000 per share, for a total redemption of $ 9.4 million.

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	3 Months Ended
	Mar. 31, 2022
Equity Incentive Plans [Abstract]
Summary of Status of Restricted Shares	Number of Shares Awarded Weighted Average Grant Date Fair Value Non-vested at January 1, 2022 26,700 $ 12.89 Granted 33,000 16.00 Vested ( 6,750 ) 12.89 Forfeited - - Non-vested at March 31, 2022 52,950 $ 14.83 Number of Shares Awarded Weighted Average Grant Date Fair Value Non-vested at January 1, 2021 22,304 $ 12.46 Granted 26,700 12.89 Vested - - Forfeited - - Non-vested at March 31, 2021 49,004 $ 12.70
Summary of Stock Option Activity	Number of Option Shares Range of Exercise Prices Weighted Average Exercise Price Outstanding at January 1, 2022 1,194,425 $ 9.02 - 13.68 $ 11.64 Options granted - - - Options exercised - - - Options forfeited - - - Options expired - - - Outstanding at March 31, 2022 1,194,425 $ 9.02 - 13.68 $ 11.64

Net Income per Common Share (Ta

Net Income per Common Share (Tables)	3 Months Ended
	Mar. 31, 2022
Net Income per Common Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	For the Three Months Ended March 31, 2022 2021 Income Shares Per Share Income Shares Per Share (Numerator) (Denominator) Amount (Numerator) (Denominator) Amount (In Thousands, except per share data) Net income available to common stockholders $ 9,676 $ 6,834 Basic earnings per share: Income available to common stockholders $ 9,676 16,980 $ 0.57 $ 6,834 17,115 $ 0.40 Effect of dilutive securities: Stock options - 363 - 117 Diluted earnings per share: Income available to common stockholders $ 9,676 17,343 $ 0.56 $ 6,834 17,232 $ 0.40

Securities (Tables)

Securities (Tables)	3 Months Ended
	Mar. 31, 2022
Securities [Abstract]
Summary of Disaggregated Net Losses on Equity Securities	For the three months ended March 31, (In Thousands) 2022 2021 Net losses recognized during the period on equity securities held at the reporting period $ ( 2,626 ) $ ( 196 ) Net losses recognized during the period on equity securities sold during the period ( 59 ) - Realized and unrealized losses on equity investments during the reporting period $ ( 2,685 ) $ ( 196 )
Amortized Cost and Gross Unrealized Gains and Losses on Securities Available for Sale	March 31, 2022 Gross Gross Amortized Unrealized Unrealized Cost Gains Losses Fair Value (In Thousands) Residential Mortgage-backed securities: Less than one year $ 2,930 $ - $ 115 $ 2,815 More than one to five years 28 - - 28 More than five to ten years 5,817 1 133 5,685 More than ten years 24,983 22 1,101 23,904 Sub-total: 33,758 23 1,349 32,432 Corporate Debt securities: More than five to ten years 49,226 1,104 560 49,770 Sub-total: 49,226 1,104 560 49,770 Municipal obligations: More than ten years 4,078 27 - 4,105 Sub-total: 4,078 27 - 4,105 Total securities $ 87,062 $ 1,154 $ 1,909 $ 86,307 December 31, 2021 Gross Gross Amortized Unrealized Unrealized Cost Gains Losses Fair Value (In Thousands) Residential Mortgage-backed securities: Due within one year $ 2,952 $ - $ 114 $ 2,838 More than one to five years 53 - - 53 More than five to ten years 6,317 165 27 6,455 More than ten years 21,555 298 287 21,566 Sub-total: 30,877 463 428 30,912 Corporate Debt securities: More than five to ten years 47,765 2,465 159 50,071 Sub-total: 47,765 2,465 159 50,071 Municipal obligations: Due after ten years 4,104 99 - 4,203 Sub-total: 4,104 99 - 4,203 Total Debt Securities Available $ 82,746 $ 3,027 $ 587 $ 85,186
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	12 Months or Less More than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses (In Thousands) March 31, 2022 Residential mortgage-backed securities $ 24,077 $ 783 $ 5,178 $ 566 $ 29,255 $ 1,349 Corporate Debt securities 17,883 560 - - 17,883 560 $ 41,960 $ 1,343 $ 5,178 $ 566 $ 47,138 $ 1,909 December 31, 2021 Residential mortgage-backed securities $ 7,801 $ 159 $ 4,681 $ 269 $ 12,482 $ 428 Corporate Debt Securities 12,324 159 - - 12,324 159 $ 20,125 $ 318 $ 4,681 $ 269 $ 24,806 $ 587

Loans Receivable and Allowanc_2

Loans Receivable and Allowance for Loan Losses (Tables)	3 Months Ended
	Mar. 31, 2022
Loans Receivable and Allowance for Loan Losses [Abstract]
Recorded Investment in Loans Receivable	March 31, 2022 December 31, 2021 (In Thousands) Residential one-to-four family $ 233,251 $ 224,534 Commercial and multi-family 1,804,815 1,720,174 Construction 141,082 153,904 Commercial business (1) 198,216 191,139 Home equity (2) 52,279 50,469 Consumer 2,726 3,717 2,432,369 2,343,937 Less: Deferred loan fees, net ( 2,459 ) ( 1,876 ) Allowance for loan losses ( 33,980 ) ( 37,119 ) Total Loans, net $ 2,395,930 $ 2,304,942 (1) Includes business lines of credit. (2) Includes home equity lines of credit.
Allowance for Loan Losses	The following table sets forth the activity in the Company’s allowance for loan losses for the three months ended March 31, 2022, and the related portion of the allowances for loan losses that is allocated to each loan class, as of March 31, 2022 (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for credit losses: Beginning Balance, January 1, 2022 $ 4,094 $ 22,065 $ 2,231 $ 8,000 $ 533 $ 14 182 $ 37,119 Charge-offs: - - - ( 766 ) - - - ( 766 ) Recoveries: - - - 1 3 198 - 202 (Reversals) provisions: ( 1,593 ) ( 1,245 ) ( 266 ) 901 ( 202 ) ( 197 ) 27 ( 2,575 ) Ending Balance, March 31, 2022 2,501 20,820 1,965 8,136 334 15 209 33,980 Ending Balance attributable to loans: Individually evaluated for impairment 221 618 295 6,000 10 - - 7,144 Collectively evaluated for impairment 2,280 20,202 1,670 2,136 324 15 209 26,836 Ending Balance, March 31, 2022 2,501 20,820 1,965 8,136 334 15 209 33,980 Loans Receivables: Individually evaluated for impairment 4,836 24,901 2,954 7,517 747 - - 40,955 Collectively evaluated for impairment 228,415 1,779,914 138,128 190,699 51,532 2,726 - 2,391,414 Total Gross Loans: $ 233,251 $ 1,804,815 $ 141,082 $ 198,216 $ 52,279 $ 2,726 $ - $ 2,432,369 _____________________________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table sets forth the activity in the Company’s allowance for loan losses for the three months ended March 31, 2021 (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for credit losses: Beginning Balance, January 1, 2021 $ 3,293 $ 21,772 $ 1,977 $ 6,306 $ 286 $ - $ 5 $ 33,639 Charge-offs: ( 57 ) - - - - - - ( 57 ) Recoveries: 27 - - - 3 - - 30 (Reversals) provisions: ( 426 ) 1,347 25 275 4 - 640 1,865 Ending Balance, March 31, 2021 $ 2,837 $ 23,119 $ 2,002 $ 6,581 $ 293 $ - $ 645 $ 35,477 Ending Balance attributable to loans: Individually evaluated for impairment 302 381 - 4,601 23 - - 5,307 Collectively evaluated for impairment 2,535 22,738 2,002 1,980 270 - 645 30,170 Ending Balance, March 31, 2021 2,837 23,119 2,002 6,581 293 - 645 35,477 Loans Receivables: Individually evaluated for impairment 5,509 44,086 2,787 13,269 1,693 - - 67,344 Collectively evaluated for impairment 228,866 1,656,027 164,437 164,071 51,667 851 - 2,265,919 Total Gross Loans: 234,375 1,700,113 167,224 177,340 53,360 851 - 2,333,263 _____________________________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) The following table sets forth the amount recorded in loans receivable at December 31, 2021. The table also details the amount of total loans receivable that are evaluated individually, and collectively, for impairment and the related portion of the allowance for loan losses that is allocated to each loan class (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for credit losses: Ending Balance attributable to loans: Individually evaluated for impairment $ 265 $ 1,690 $ 210 $ 5,650 $ 13 $ - $ - $ 7,828 Collectively evaluated for impairment 3,829 20,375 2,021 2,350 520 14 182 29,291 Ending Balance, December 31, 2021 $ 4,094 $ 22,065 $ 2,231 $ 8,000 $ 533 $ 14 $ 182 $ 37,119 Loans Receivables: Individually evaluated for impairment $ 4,961 $ 31,745 $ 2,847 $ 8,746 $ 1,083 $ - $ - $ 49,382 Collectively evaluated for impairment 219,573 1,688,429 151,057 182,393 49,386 3,717 - 2,294,555 Total Gross Loans: $ 224,534 $ 1,720,174 $ 153,904 $ 191,139 $ 50,469 $ 3,717 $ - $ 2,343,937 (1) Includes business lines of credit. (2) Includes home equity lines of credit.
Impaired Loans	The following table summarizes the average recorded investment and interest income recognized on impaired loans with no related allowance recorded by portfolio class for the three months ended March 31, 2022 and 2021 (in thousands): Three Months Ended March 31, 2022 2022 2021 2021 Average Interest Average Interest Recorded Income Recorded Income Investment Recognized Investment Recognized Loans with no related allowance recorded: Residential one-to-four family $ 2,935 $ 37 $ 3,453 $ 34 Commercial and Multi-family 21,220 263 44,958 282 Construction - - 1,394 36 Commercial business (1) 1,952 65 5,171 13 Home equity (2) 613 5 1,196 10 Consumer - - - - Total Impaired Loans with no allowance recorded: $ 26,720 $ 370 $ 56,172 $ 375 Loans with an allowance recorded: Residential one-to-four family $ 1,964 $ - $ 2,943 $ 32 Commercial and Multi-family 7,103 - 8,013 129 Construction 2,901 2 - - Commercial business (1) 6,180 9 7,710 93 Home equity (2) 303 - 438 2 Consumer - - - - Total Impaired Loans with an allowance recorded: $ 18,451 $ 11 $ 19,104 $ 256 Total Impaired Loans: $ 45,171 $ 381 $ 75,276 $ 631 __________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table summarizes the recorded investment by portfolio class at March 31, 2022 and December 31, 2021. (in thousands): As of March 31, 2022 As of December 31, 2021 Recorded Unpaid Principal Related Recorded Unpaid Principal Related Investment Balance Allowance Investment Balance Allowance Loans with no related allowance recorded: Residential one-to-four family $ 2,920 $ 3,272 $ - $ 2,950 $ 3,300 $ - Commercial and multi-family 21,525 22,832 - 20,915 22,100 - Construction - - - - - - Commercial business (1) 1,790 5,783 - 2,114 6,905 - Home equity (2) 446 446 - 779 780 - Total Impaired Loans with no related allowance recorded: $ 26,681 $ 32,333 $ - $ 26,758 $ 33,085 $ - Loans with an allowance recorded: Residential one-to-four family $ 1,916 $ 1,937 $ 221 $ 2,011 $ 2,032 $ 265 Commercial and Multi-family 3,376 6,930 618 10,830 14,494 1,690 Construction 2,954 2,954 295 2,847 2,847 210 Commercial business (1) 5,727 16,529 6,000 6,632 17,514 5,650 Home equity (2) 301 301 10 304 304 13 Total Impaired Loans with an allowance recorded: $ 14,274 $ 28,651 $ 7,144 $ 22,624 $ 37,191 $ 7,828 Total Impaired Loans: $ 40,955 $ 60,984 $ 7,144 $ 49,382 $ 70,276 $ 7,828 __________ (1) Includes business lines of credit. (2) Includes home equity lines of credit.
Troubled Debt Restructurings	At March 31, 2022 At December 31, 2021 (In thousands) Recorded investment in TDRs: Accrual status $ 14,659 $ 12,402 Non-accrual status 390 3,570 Total recorded investment in TDRs $ 15,049 $ 15,972
Delinquency Status of Total Loans	The following table sets forth the delinquency status of total loans receivable as of March 31, 2022: Loans Receivable 30-59 Days 60-90 Days Greater Than Total Past Total Loans >90 Days Past Due Past Due 90 Days Due Current Receivable and Accruing (In Thousands) Residential one-to-four family $ 327 $ - $ 86 $ 413 $ 232,838 $ 233,251 $ - Commercial and multi-family 1,983 - 757 2,740 1,802,075 1,804,815 - Construction - - 2,954 2,954 138,128 141,082 - Commercial business (1) 3,623 4 2,932 6,559 191,657 198,216 - Home equity (2) 188 - - 188 52,091 52,279 - Consumer - - - - 2,726 2,726 - Total $ 6,121 $ 4 $ 6,729 $ 12,854 $ 2,419,515 $ 2,432,369 $ - _________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table sets forth the delinquency status of total loans receivable at December 31, 2021: Loans Receivable 30-59 Days 60-90 Days Greater Than Total Past Total Loans >90 Days Past Due Past Due 90 Days Due Current Receivable and Accruing (In Thousands) Residential one-to-four family $ 1,063 $ - $ 86 $ 1,149 $ 223,385 $ 224,534 $ - Commercial and multi-family 1,181 - 5,167 6,348 1,713,826 1,720,174 - Construction 2,899 - 2,847 5,746 148,158 153,904 - Commercial business (1) 405 166 6,775 7,346 183,793 191,139 3,124 Home equity (2) 190 - 27 217 50,252 50,469 - Consumer - - - - 3,717 3,717 - Total $ 5,738 $ 166 $ 14,902 $ 20,806 $ 2,323,131 $ 2,343,937 $ 3,124 (1) Includes business lines of credit. (2) Includes home equity lines of credit.
Non-Accruing Loans	As of March 31, 2022 As of December 31, 2021 (In Thousands) (In Thousands) Non-Accruing Loans: Residential one-to-four family $ 278 $ 282 Commercial and multi-family 757 8,601 Construction 2,954 2,847 Commercial business (1) 5,243 3,132 Home equity (2) - 27 Total $ 9,232 $ 14,889 _________ (1) Includes business lines of credit. (2) Includes home equity lines of credit.
Loan Portfolio by Pass Rating	Pass Special Mention Substandard Total Residential one-to-four family $ 232,476 $ 498 $ 277 $ 233,251 Commercial and multi-family 1,741,596 43,908 19,311 1,804,815 Construction 138,128 - 2,954 141,082 Commercial business (1) 186,148 4,972 7,096 198,216 Home equity (2) 52,067 - 212 52,279 Consumer 2,726 - - 2,726 Total Gross Loans $ 2,353,141 $ 49,378 $ 29,850 $ 2,432,369 _________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table presents the loan portfolio types summarized by the aggregate pass rating and the classified ratings of special mention and substandard within the Company’s internal risk rating system as of December 31, 2021 (in thousands). As of December 31, 2021, the Company had no loans with the classified rating of doubtful or loss. Pass Special Mention Substandard Total Residential one-to-four family $ 223,660 $ 505 $ 369 $ 224,534 Commercial and multi-family 1,647,701 45,087 27,386 1,720,174 Construction 151,057 - 2,847 153,904 Commercial business (1) 178,056 4,767 8,316 191,139 Home equity (2) 50,230 - 239 50,469 Consumer 3,717 - - 3,717 Total Gross Loans $ 2,254,421 $ 50,359 $ 39,157 $ 2,343,937 ________ (1) Includes business lines of credit. (2) Includes home equity lines of credit.

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value of Financial Instruments [Abstract]
Fair Value Measurements, Recurring	(Level 1) (Level 2) Quoted Prices in Significant (Level 3) Active Markets Other Significant for Identical Observable Unobservable Description Total Assets Inputs Inputs As of March 31, 2022: Securities Debt Securities Available for Sale $ 86,307 $ - $ 86,307 $ - Marketable Equities $ 21,269 $ 21,269 $ - $ - Total Securities $ 107,576 $ 21,269 $ 86,307 $ - As of December 31, 2021: Securities Debt Securities Available for Sale $ 85,186 $ - $ 85,186 $ - Marketable Equities $ 25,187 $ 25,187 $ - $ - Total Securities $ 110,373 $ 25,187 $ 85,186 $ -
Fair Value Measurements, Nonrecurring	(Level 1) (Level 2) Quoted Prices in Significant (Level 3) Active Markets Other Significant for Identical Observable Unobservable Description Total Assets Inputs Inputs As of March 31, 2022 Impaired Loans $ 7,130 $ - $ - $ 7,130 Other real estate owned $ 75 $ - $ - $ 75 As of December 31, 2021: Impaired Loans $ 14,796 $ - $ - $ 14,796 Other real estate owned $ 75 $ - $ - $ 75
Quantitative Information about Level 3 Fair Value Measurements	Quantitative Information about Level 3 Fair Value Measurements Fair Value Valuation Unobservable Estimate Techniques Input Range March 31, 2022: Impaired Loans $ 7,130 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Other real estate owned $ 75 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Fair Value Valuation Unobservable Estimate Techniques Input Range December 31, 2021: Impaired Loans $ 14,796 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Other real estate owned $ 75 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % (1) Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various level 3 inputs which are not objectively determinable. (2) Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The range of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal.
Carrying Values and Estimated Fair Values of Financial Instruments	As of March 31, 2022 Quoted Prices in Active Significant Significant Carrying Markets for Identical Assets Other Observable Inputs Unobservable Inputs Value Fair Value (Level 1) (Level 2) (Level 3) (In Thousands) Financial assets: Cash and cash equivalents $ 396,653 $ 396,653 $ 396,653 $ - $ - Interest-earning time deposits 735 735 - 735 - Debt securities available for sale 86,307 86,307 - 86,307 - Equity investments 21,269 21,269 21,269 - - Loans held for sale 325 325 - 325 - Loans receivable, net 2,395,930 2,333,896 - - 2,333,896 FHLB of New York stock, at cost 6,128 6,128 - 6,128 - Accrued interest receivable 9,593 9,593 - 9,593 - Financial liabilities: Deposits 2,631,175 2,532,283 1,949,169 583,114 - Borrowings 71,848 68,572 - 68,572 - Subordinated debentures 37,333 43,354 - 43,354 - Accrued interest payable 553 553 - 553 - As of December 31, 2021 Quoted Prices in Active Significant Significant Carrying Markets for Identical Assets Other Observable Inputs Unobservable Inputs Value Fair Value (Level 1) (Level 2) (Level 3) (In Thousands) Financial assets: Cash and cash equivalents $ 411,629 $ 411,629 $ 411,629 $ - $ - Interest-earning time deposits 735 735 - 735 - Debt securities available for sale 85,186 85,186 - 85,186 - Equity investments 25,187 25,187 25,187 - - Loans held for sale 952 952 - 952 - Loans receivable, net 2,304,942 2,313,204 - - 2,313,204 FHLB of New York stock, at cost 6,084 6,084 - 6,084 - Accrued interest receivable 9,183 9,183 - 9,183 - Financial liabilities: Deposits 2,561,402 2,520,191 1,881,121 639,070 - Debt 71,711 71,214 - 71,214 - Subordinated debentures 37,275 45,020 - 45,020 - Accrued interest payable 1,051 1,051 - 1,051 -

Lease Obligations (Tables)

Lease Obligations (Tables)	3 Months Ended
	Mar. 31, 2022
Lease Obligations [Abstract]
Schedule of Lease Information	Three Months Ended March 31, 2022 Three Months Ended March 31, 2021 Operating lease cost $ 902 $ 952 Variable lease cost-operating leases $ 218 $ 246 At March 31, 2022 At December 31, 2021 Supplemental balance sheet information related to leases: Operating Leases Operating lease right-of-use assets $ 11,883 $ 12,457 Current liabilities $ 3,123 $ 3,296 Operating lease liabilities (noncurrent portion) 10,057 10,529 Imputed Interest ( 1,000 ) ( 1,073 ) Total operating lease liabilities $ 12,180 $ 12,752
Summary of Maturity of Lease Obligations for Operating Leases	Maturities of lease liabilities: At March 31, 2022 At December 31, 2021 Operating Leases Operating Leases One year or less $ 3,123 $ 3,296 Over one year through three years 4,322 4,455 Over three years through five years 2,986 3,012 Over five years 2,749 3,062 Gross Operating Lease Liabilities $ 13,180 $ 13,825 Imputed Expenses ( 1,000 ) ( 1,073 ) Total Operating Lease Liabilities $ 12,180 $ 12,752

Equity Incentive Plans (Narrati

Equity Incentive Plans (Narrative) (Details) - USD ($)	Jan. 12, 2022	Apr. 26, 2021	Feb. 19, 2021	Feb. 10, 2021	Mar. 31, 2022	Mar. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Options granted
Stock option expense					$ 45,000	$ 50,000
Options [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares underlying unexercised options					304,000
Expected future compensation expense, unexercised options					$ 534,000
Expected future compensation expense, weighted average period for recognition					4 years 3 months 21 days
Options Exercisable - Number of Option Shares					890,325
Restricted Stock [Member]
Defined Benefit Plan Disclosure [Line Items]
Expected future expenses relating to non-vested restricted shares					$ 690,000
Expected future compensation expense, weighted average period for recognition					3 years 5 months 19 days
2018 Equity Incentive Plan [Member] | Maximum [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares authorized for issuance					1,000,000
2011 Stock Plan [Member] | Maximum [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares authorized for issuance					900,000
Directors [Member]
Defined Benefit Plan Disclosure [Line Items]
Vesting period	4 years
Directors [Member] | Restricted Stock [Member]
Defined Benefit Plan Disclosure [Line Items]
Restricted stock issued	33,000
Directors [Member] | 2018 Equity Incentive Plan [Member] | Options [Member]
Defined Benefit Plan Disclosure [Line Items]
Options granted				66,000
Vesting period				5 years
Directors [Member] | 2018 Equity Incentive Plan [Member] | Restricted Stock [Member]
Defined Benefit Plan Disclosure [Line Items]
Restricted stock issued			300	26,400
Vesting period			2 years	4 years
Certain Officers [Member]
Defined Benefit Plan Disclosure [Line Items]
Options granted		6,800
Vesting period		5 years

Equity Incentive Plans (Summary

Equity Incentive Plans (Summary of Status of Restricted Shares) (Details) - $ / shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Equity Incentive Plans [Abstract]
Number of Shares Awarded, Non-vested at beginning of period	26,700	22,304
Number of Shares Awarded, Granted	33,000	26,700
Number of Shares Awarded, Vested	(6,750)
Number of Shares Awarded, Forfeited
Number of Shares Awarded, Non-vested at end of period	52,950	49,004
Weighted Average Grant Date Fair Value, Non-vested at beginning of period	$ 12.89	$ 12.46
Weighted Average Grant Date Fair Value, Granted	16	12.89
Weighted Average Grant Date Fair Value, Vested	12.89
Weighted Average Grant Date Fair Value, Forfeited
Weighted Average Grant Date Fair Value, Non-vested at end of period	$ 14.83	$ 12.70

Equity Incentive Plans (Summa_2

Equity Incentive Plans (Summary of Stock Option Activity) (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Equity Incentive Plans [Abstract]
Outstanding, Beginning Balance - Number of Options	1,194,425
Options Granted - Number of Options
Options Exercised - Number of Options
Options Forfeited - Number of Options
Options Expired - Number of Options
Outstanding, Ending Balance - Number of Options	1,194,425	1,194,425
Outstanding, Range of Exercise Price, Lower Range Limit (per share)	$ 9.02	$ 9.02
Outstanding, Range of Exercise Price, Upper Range Limit (per share)	13.68	13.68
Options Granted, Exercise Price
Options Exercised - Exercise Price
Options Forfeited - Exercise Price
Options expired - Exercise prices
Outstanding Number of Options, Beginning Balance - Weighted Average Exercise Price	11.64
Number of Options Granted - Weighted Average Exercise Price
Number of Options, Exercised - Weighted Average Exercise Price
Number of Options Forfeited - Weighted Average Exercise Price
Number of Options Expired - Weighted Average Exercise Price
Outstanding Number of Options, Ending Balance - Weighted Average Exercise Price	$ 11.64	$ 11.64

Net Income per Common Share (Na

Net Income per Common Share (Narrative) (Details) - shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Net Income per Common Share [Abstract]
Anti-dilutive outstanding options	0	0

Net Income Per Common Share (Sc

Net Income Per Common Share (Schedule of Earnings Per Share, Basic and Diluted) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Net Income per Common Share [Abstract]
Net income available to common stockholders	$ 9,676	$ 6,834
Basic earnings per share: Income available to common stockholders	9,676	6,834
Diluted earnings per share: Income available to common stockholders	$ 9,676	$ 6,834
Basic earnings per share: Income available to common stockholders, Shares	16,980	17,115
Effect of dilutive securities: Stock options: Shares	363	117
Diluted earnings per share: Income available to common stockholders, Shares	17,343	17,232
Basic earnings per share: Income available to common stockholders, Per share amount	$ 0.57	$ 0.40
Diluted earnings per share: Income available to common stockholders, Per share amount	$ 0.56	$ 0.40

Securities (Summary of Disaggre

Securities (Summary of Disaggregated Net Losses on Equity Securities) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Securities [Abstract]
Net losses recognized during the period on equity securities held at the reporting period	$ (2,626)	$ (196)
Net losses recognized during the period on equity securities sold during the period	(59)
Realized and unrealized losses on equity investments still held at the reporting date	$ (2,685)	$ (196)

Securities (Amortized Cost and

Securities (Amortized Cost and Gross Unrealized Gains and Losses on Securities Available for Sale) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Schedule of Available-for-sale Securities [Line Items]
Debt Securities, Amortized Cost	$ 87,062	$ 82,746
Debt securities: Gross Unrealized Gains	1,154	3,027
Debt securities: Gross Unrealized Losses	1,909	587
Debt securities: Fair Value	86,307	85,186
Residential Mortgage-backed securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt securities, Less than one year, Amortized Cost	2,930	2,952
Debt securities, More than one to five years, Amortized Cost	28	53
Debt securities, More than five to ten years, Amortized Cost	5,817	6,317
Debt securities, More than ten years, Amortized Cost	24,983	21,555
Debt Securities, Amortized Cost	33,758	30,877
Debt securities: More than five to ten years, Gross Unrealized Gains	1	165
Debt securities, More than ten years, Gross Unrealized Gains	22	298
Debt securities: Gross Unrealized Gains	23	463
Debt securities: Due within one year, Gross Unrealized Losses	115	114
Debt securities: More than five to ten years, Gross Unrealized Losses	133	27
Debt securities: More than ten years, Gross Unrealized Losses	1,101	287
Debt securities: Gross Unrealized Losses	1,349	428
Debt securities: Due within one year, Fair Value	2,815	2,838
Debt securities: More than one to five years, Fair Value	28	53
Debt securities: More than five to ten years, Fair Value	5,685	6,455
Debt securities: More than ten years, Fair Value	23,904	21,566
Debt securities: Fair Value	32,432	30,912
Corporate Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt securities, More than five to ten years, Amortized Cost	49,226	47,765
Debt Securities, Amortized Cost	49,226	47,765
Debt securities: More than five to ten years, Gross Unrealized Gains	1,104	2,465
Debt securities: Gross Unrealized Gains	1,104	2,465
Debt securities: More than five to ten years, Gross Unrealized Losses	560	159
Debt securities: Gross Unrealized Losses	560	159
Debt securities: More than five to ten years, Fair Value	49,770	50,071
Debt securities: Fair Value	49,770	50,071
Municipal Obligations [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt securities, More than ten years, Amortized Cost	4,078	4,104
Debt Securities, Amortized Cost	4,078	4,104
Debt securities, More than ten years, Gross Unrealized Gains	27	99
Debt securities: Gross Unrealized Gains	27	99
Debt securities: More than ten years, Fair Value	4,105	4,203
Debt securities: Fair Value	$ 4,105	$ 4,203

Securities (Available-for-Sale

Securities (Available-for-Sale Securities, Continuous Unrealized Loss Position, Fair Value ) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Schedule of Available-for-sale Securities [Line Items]
Debt Securities, 12 Months or Less - Fair Value	$ 41,960	$ 20,125
Debt Securities, More than 12 Months - Fair Value	5,178	4,681
Debt Securities - Total Fair Value	47,138	24,806
Debt Securities, 12 Months or Less - Unrealized Losses	1,343	318
Debt Securities, More than 12 Months - Unrealized Losses	566	269
Debt Securities - Total Unrealized Losses	1,909	587
Residential Mortgage-backed securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt Securities, 12 Months or Less - Fair Value	24,077	7,801
Debt Securities, More than 12 Months - Fair Value	5,178	4,681
Debt Securities - Total Fair Value	29,255	12,482
Debt Securities, 12 Months or Less - Unrealized Losses	783	159
Debt Securities, More than 12 Months - Unrealized Losses	566	269
Debt Securities - Total Unrealized Losses	1,349	428
Corporate Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt Securities, 12 Months or Less - Fair Value	17,883	12,324
Debt Securities - Total Fair Value	17,883	12,324
Debt Securities, 12 Months or Less - Unrealized Losses	560	159
Debt Securities - Total Unrealized Losses	$ 560	$ 159

Loans Receivable and Allowanc_3

Loans Receivable and Allowance for Loan Losses (Narrative) (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2022USD ($)loan	Mar. 31, 2021USD ($)loan	Dec. 31, 2021USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans, interest income lost	$ 246,000		$ 1,300,000
Loans Receivable >90 Days and Accruing	0		3,124,000
Loans acquired with deteriorated credit quality, fair value	$ 665,000		668,000
Troubled debt restructurings, number | loan	1	1
Troubled debt restructurings, amount	$ 115,388	$ 96,532
Troubled debt restructurings, subsequent default, amount	0	$ 127,449
Troubled debt restructuring, subsequent default, number | loan		1
Loans Receivable within 90 Days	9,232,000		14,889,000
Loans receivable, gross	2,432,369,000	$ 2,333,263,000	2,343,937,000
Less Than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans Receivable within 90 Days	3,300,000		3,800,000
Doubtful [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	0		0
Loss [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 0		$ 0

Loans Receivable and Allowanc_4

Loans Receivable and Allowance for Loan Losses (Recorded Investment in Loans Receivable) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 2,432,369	$ 2,343,937	$ 2,333,263
Deferred loan fees, net	(2,459)	(1,876)
Allowance for loan losses	(33,980)	(37,119)
Net Loans	2,395,930	2,304,942
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	233,251	224,534	234,375
Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	1,804,815	1,720,174	1,700,113
Construction Loans In Process [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	141,082	153,904	167,224
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	198,216	191,139	177,340
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	52,279	50,469	53,360
Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 2,726	$ 3,717	$ 851

Loans Receivable and Allowanc_5

Loans Receivable and Allowance for Loan Losses (Allowance for Loan Losses) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	$ 37,119	$ 33,639
Allowance for loan losses: Charge-offs	(766)	(57)
Allowance for loan losses: Recovery	202	30
Allowance for loan losses: Provisions	(2,575)	1,865
Allowance for loan losses: Ending balance: individually evaluated for impairment	7,144	5,307	$ 7,828
Allowance for loan losses: Ending balance: collectively evaluated for impairment	26,836	30,170	29,291
Allowance for loan losses: Ending Balance	33,980	35,477
Loans receivables: Ending balance: individually evaluated for impairment	40,955	67,344	49,382
Loans receivables: Ending balance: collectively evaluated for impairment	2,391,414	2,265,919	2,294,555
Loans receivables: Ending balance	2,432,369	2,333,263	2,343,937
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	4,094	3,293
Allowance for loan losses: Charge-offs		(57)
Allowance for loan losses: Recovery		27
Allowance for loan losses: Provisions	(1,593)	(426)
Allowance for loan losses: Ending balance: individually evaluated for impairment	221	302	265
Allowance for loan losses: Ending balance: collectively evaluated for impairment	2,280	2,535	3,829
Allowance for loan losses: Ending Balance	2,501	2,837
Loans receivables: Ending balance: individually evaluated for impairment	4,836	5,509	4,961
Loans receivables: Ending balance: collectively evaluated for impairment	228,415	228,866	219,573
Loans receivables: Ending balance	233,251	234,375	224,534
Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	22,065	21,772
Allowance for loan losses: Provisions	(1,245)	1,347
Allowance for loan losses: Ending balance: individually evaluated for impairment	618	381	1,690
Allowance for loan losses: Ending balance: collectively evaluated for impairment	20,202	22,738	20,375
Allowance for loan losses: Ending Balance	20,820	23,119
Loans receivables: Ending balance: individually evaluated for impairment	24,901	44,086	31,745
Loans receivables: Ending balance: collectively evaluated for impairment	1,779,914	1,656,027	1,688,429
Loans receivables: Ending balance	1,804,815	1,700,113	1,720,174
Construction Loans In Process [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	2,231	1,977
Allowance for loan losses: Provisions	(266)	25
Allowance for loan losses: Ending balance: individually evaluated for impairment	295		210
Allowance for loan losses: Ending balance: collectively evaluated for impairment	1,670	2,002	2,021
Allowance for loan losses: Ending Balance	1,965	2,002
Loans receivables: Ending balance: individually evaluated for impairment	2,954	2,787	2,847
Loans receivables: Ending balance: collectively evaluated for impairment	138,128	164,437	151,057
Loans receivables: Ending balance	141,082	167,224	153,904
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	8,000	6,306
Allowance for loan losses: Charge-offs	(766)
Allowance for loan losses: Recovery	1
Allowance for loan losses: Provisions	901	275
Allowance for loan losses: Ending balance: individually evaluated for impairment	6,000	4,601	5,650
Allowance for loan losses: Ending balance: collectively evaluated for impairment	2,136	1,980	2,350
Allowance for loan losses: Ending Balance	8,136	6,581
Loans receivables: Ending balance: individually evaluated for impairment	7,517	13,269	8,746
Loans receivables: Ending balance: collectively evaluated for impairment	190,699	164,071	182,393
Loans receivables: Ending balance	198,216	177,340	191,139
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	533	286
Allowance for loan losses: Recovery	3	3
Allowance for loan losses: Provisions	(202)	4
Allowance for loan losses: Ending balance: individually evaluated for impairment	10	23	13
Allowance for loan losses: Ending balance: collectively evaluated for impairment	324	270	520
Allowance for loan losses: Ending Balance	334	293
Loans receivables: Ending balance: individually evaluated for impairment	747	1,693	1,083
Loans receivables: Ending balance: collectively evaluated for impairment	51,532	51,667	49,386
Loans receivables: Ending balance	52,279	53,360	50,469
Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	14
Allowance for loan losses: Recovery	198
Allowance for loan losses: Provisions	(197)
Allowance for loan losses: Ending balance: collectively evaluated for impairment	15		14
Allowance for loan losses: Ending Balance	15
Loans receivables: Ending balance: collectively evaluated for impairment	2,726	851	3,717
Loans receivables: Ending balance	2,726	851	3,717
Unallocated [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	182	5
Allowance for loan losses: Provisions	27	640
Allowance for loan losses: Ending balance: collectively evaluated for impairment	209	645	$ 182
Allowance for loan losses: Ending Balance	$ 209	$ 645

Loans Receivable and Allowanc_6

Loans Receivable and Allowance for Loan Losses (Impaired Loans) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	$ 26,720	$ 56,172
Average Recorded Investment - With an allowance recorded	18,451	19,104
Average Recorded Investment - Total	45,171	75,276
Interest Income Recognized - With no related allowance recorded	370	375
Interest Income Recognized - With an allowance recorded	11	256
Interest Income Recognized - Total	381	631
Recorded Investment - With no related allowance recorded	26,681		$ 26,758
Recorded Investment - With an allowance recorded	14,274		22,624
Recorded Investment - Total	40,955		49,382
Unpaid Principal Balance - With no related allowance recorded	32,333		33,085
Unpaid Principal Balance - With an allowance recorded	28,651		37,191
Unpaid Principal Balance - Total	60,984		70,276
Related Allowance	7,144		7,828
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	2,935	3,453
Average Recorded Investment - With an allowance recorded	1,964	2,943
Interest Income Recognized - With no related allowance recorded	37	34
Interest Income Recognized - With an allowance recorded		32
Recorded Investment - With no related allowance recorded	2,920		2,950
Recorded Investment - With an allowance recorded	1,916		2,011
Unpaid Principal Balance - With no related allowance recorded	3,272		3,300
Unpaid Principal Balance - With an allowance recorded	1,937		2,032
Related Allowance	221		265
Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	21,220	44,958
Average Recorded Investment - With an allowance recorded	7,103	8,013
Interest Income Recognized - With no related allowance recorded	263	282
Interest Income Recognized - With an allowance recorded		129
Recorded Investment - With no related allowance recorded	21,525		20,915
Recorded Investment - With an allowance recorded	3,376		10,830
Unpaid Principal Balance - With no related allowance recorded	22,832		22,100
Unpaid Principal Balance - With an allowance recorded	6,930		14,494
Related Allowance	618		1,690
Construction Loans In Process [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded		1,394
Average Recorded Investment - With an allowance recorded	2,901
Interest Income Recognized - With no related allowance recorded		36
Interest Income Recognized - With an allowance recorded	2
Recorded Investment - With an allowance recorded	2,954		2,847
Unpaid Principal Balance - With an allowance recorded	2,954		2,847
Related Allowance	295		210
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	1,952	5,171
Average Recorded Investment - With an allowance recorded	6,180	7,710
Interest Income Recognized - With no related allowance recorded	65	13
Interest Income Recognized - With an allowance recorded	9	93
Recorded Investment - With no related allowance recorded	1,790		2,114
Recorded Investment - With an allowance recorded	5,727		6,632
Unpaid Principal Balance - With no related allowance recorded	5,783		6,905
Unpaid Principal Balance - With an allowance recorded	16,529		17,514
Related Allowance	6,000		5,650
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	613	1,196
Average Recorded Investment - With an allowance recorded	303	438
Interest Income Recognized - With no related allowance recorded	5	10
Interest Income Recognized - With an allowance recorded		$ 2
Recorded Investment - With no related allowance recorded	446		779
Recorded Investment - With an allowance recorded	301		304
Unpaid Principal Balance - With no related allowance recorded	446		780
Unpaid Principal Balance - With an allowance recorded	301		304
Related Allowance	$ 10		$ 13

Loans Receivable and Allowanc_7

Loans Receivable and Allowance for Loan Losses (Troubled Debt Restructurings) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Financing Receivable, Modifications [Line Items]
Total recorded investment in TDRs	$ 15,049	$ 15,972
Performing Financing Receivable [Member]
Financing Receivable, Modifications [Line Items]
Total recorded investment in TDRs	14,659	12,402
Nonperforming Financing Receivable [Member]
Financing Receivable, Modifications [Line Items]
Total recorded investment in TDRs	$ 390	$ 3,570

Loans Receivable and Allowanc_8

Loans Receivable and Allowance for Loan Losses (Delinquency Status of Total Loans) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	$ 2,432,369	$ 2,343,937
Loans Receivable >90 Days and Accruing	0	3,124
Total Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	12,854	20,806
30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	6,121	5,738
60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	4	166
Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	6,729	14,902
Current [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,419,515	2,323,131
Originated loans [Member] | Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	233,251	224,534
Loans Receivable >90 Days and Accruing
Originated loans [Member] | Residential [Member] | Total Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	413	1,149
Originated loans [Member] | Residential [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	327	1,063
Originated loans [Member] | Residential [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	86	86
Originated loans [Member] | Residential [Member] | Current [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	232,838	223,385
Originated loans [Member] | Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	1,804,815	1,720,174
Loans Receivable >90 Days and Accruing
Originated loans [Member] | Commercial & Multi-family [Member] | Total Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,740	6,348
Originated loans [Member] | Commercial & Multi-family [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	1,983	1,181
Originated loans [Member] | Commercial & Multi-family [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	757	5,167
Originated loans [Member] | Commercial & Multi-family [Member] | Current [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	1,802,075	1,713,826
Originated loans [Member] | Construction Loans In Process [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	141,082	153,904
Loans Receivable >90 Days and Accruing
Originated loans [Member] | Construction Loans In Process [Member] | Total Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,954	5,746
Originated loans [Member] | Construction Loans In Process [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable		2,899
Originated loans [Member] | Construction Loans In Process [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,954	2,847
Originated loans [Member] | Construction Loans In Process [Member] | Current [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	138,128	148,158
Originated loans [Member] | Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	198,216	191,139
Loans Receivable >90 Days and Accruing		3,124
Originated loans [Member] | Commercial Business [Member] | Total Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	6,559	7,346
Originated loans [Member] | Commercial Business [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	3,623	405
Originated loans [Member] | Commercial Business [Member] | 60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	4	166
Originated loans [Member] | Commercial Business [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,932	6,775
Originated loans [Member] | Commercial Business [Member] | Current [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	191,657	183,793
Originated loans [Member] | Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	52,279	50,469
Loans Receivable >90 Days and Accruing
Originated loans [Member] | Home Equity [Member] | Total Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	188	217
Originated loans [Member] | Home Equity [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	188	190
Originated loans [Member] | Home Equity [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable		27
Originated loans [Member] | Home Equity [Member] | Current [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	52,091	50,252
Originated loans [Member] | Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,726	3,717
Loans Receivable >90 Days and Accruing
Originated loans [Member] | Consumer [Member] | Current [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	$ 2,726	$ 3,717

Loans Receivable and Allowanc_9

Loans Receivable and Allowance for Loan Losses (Non-Accruing Loans) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	$ 9,232	$ 14,889
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	278	282
Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	757	8,601
Construction Loans In Process [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	2,954	2,847
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	$ 5,243	3,132
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans		$ 27

Loans Receivable and Allowan_10

Loans Receivable and Allowance for Loan Losses (Loan Portfolio by Pass Rating) (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 2,432,369,000	$ 2,343,937,000	$ 2,333,263,000
Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	2,353,141,000	2,254,421,000
Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	49,378,000	50,359,000
Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	29,850,000	39,157,000
Doubtful [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	0	0
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	233,251,000	224,534,000	234,375,000
Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	1,804,815,000	1,720,174,000	1,700,113,000
Construction Loans In Process [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	141,082,000	153,904,000	167,224,000
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	198,216,000	191,139,000	177,340,000
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	52,279,000	50,469,000	53,360,000
Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	2,726,000	3,717,000	$ 851,000
Originated loans [Member] | Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	233,251,000	224,534,000
Originated loans [Member] | Residential [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	232,476,000	223,660,000
Originated loans [Member] | Residential [Member] | Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	498,000	505,000
Originated loans [Member] | Residential [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	277,000	369,000
Originated loans [Member] | Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	1,804,815,000	1,720,174,000
Originated loans [Member] | Commercial & Multi-family [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	1,741,596,000	1,647,701,000
Originated loans [Member] | Commercial & Multi-family [Member] | Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	43,908,000	45,087,000
Originated loans [Member] | Commercial & Multi-family [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	19,311,000	27,386,000
Originated loans [Member] | Construction Loans In Process [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	141,082,000	153,904,000
Originated loans [Member] | Construction Loans In Process [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	138,128,000	151,057,000
Originated loans [Member] | Construction Loans In Process [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	2,954,000	2,847,000
Originated loans [Member] | Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	198,216,000	191,139,000
Originated loans [Member] | Commercial Business [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	186,148,000	178,056,000
Originated loans [Member] | Commercial Business [Member] | Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	4,972,000	4,767,000
Originated loans [Member] | Commercial Business [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	7,096,000	8,316,000
Originated loans [Member] | Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	52,279,000	50,469,000
Originated loans [Member] | Home Equity [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	52,067,000	50,230,000
Originated loans [Member] | Home Equity [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	212,000	239,000
Originated loans [Member] | Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	2,726,000	3,717,000
Originated loans [Member] | Consumer [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 2,726,000	$ 3,717,000

Stockholders' Equity (Narrative

Stockholders' Equity (Narrative) (Details) - USD ($)	Mar. 24, 2022	Feb. 04, 2022	Dec. 21, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Stockholders' Equity Note [Line Items]
Preferred stock, par value per share				$ 0.01		$ 0.01
Preferred stock redeemed, value				$ 5,330,000
Series H Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred stock, dividend rate				3.50%	3.50%	3.50%
Series G Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred stock, dividend rate		6.00%			6.00%	6.00%
Preferred stock redeemed, shares		533
Preferred stock, redemption price		$ 10,000
Preferred stock redeemed, value		$ 5,300,000
Series I Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred stock, par value per share	$ 0.01		$ 0.01
Preferred stock, dividend rate				3.00%		3.00%
Proceeds from issuance of private placement	$ 2,620,000		$ 3,200,000
Shares issued	260		320

Bank Owned Life Insurance (Narr

Bank Owned Life Insurance (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2022
Bank Owned Life Insurance [Abstract]
Purchases of BOLI	$ 8,500
Bank owned life insurance, amount		$ 73,200

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Impairment of intangible assets	$ 0
Goodwill	5,200,000	$ 5,200,000
Core Deposit Intangibles [Member]
Amortization expense	14,000	16,000
Intangible assets, net	$ 164,000	$ 178,000
Intangible asset, useful life	10 years

Fair Value of Financial Instr_3

Fair Value of Financial Instruments (Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers between fair value hierarchy	$ 0	$ 0
Impaired loans	14,274,000		$ 22,624,000
Valuation allowance	7,144,000		7,828,000
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities	0		0
Fair Value, Measurements, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities	0		0
(Level 3) Significant Unobservable Inputs [Member] | Impaired Loans [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	14,300,000		22,600,000
Valuation allowance	$ 7,100,000		$ 7,800,000

Fair Value of Financial Instr_4

Fair Value of Financial Instruments (Fair Value Measurements, Recurring) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale	$ 86,307	$ 85,186
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale	86,307	85,186
Marketable Equities	21,269	25,187
Total Securities	107,576	110,373
(Level 1) Quoted Prices in Active Markets for Identical Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Equities	21,269	25,187
(Level 1) Quoted Prices in Active Markets for Identical Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale
Marketable Equities	21,269	25,187
Total Securities	21,269	25,187
(Level 2) Significant Other Observable Inputs [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale	86,307	85,186
(Level 2) Significant Other Observable Inputs [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale	86,307	85,186
Total Securities	86,307	85,186
(Level 3) Significant Unobservable Inputs [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale
Marketable Equities
Total Securities

Fair Value of Financial Instr_5

Fair Value of Financial Instruments (Fair Value Measurements, Nonrecurring) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	$ 7,130	$ 14,796
Other real estate owned	75	75
(Level 1) Quoted Prices in Active Markets for Identical Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans
Other real estate owned
(Level 2) Significant Other Observable Inputs [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans
Other real estate owned
(Level 3) Significant Unobservable Inputs [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	7,130	14,796
Other real estate owned	$ 75	$ 75

Fair Value of Financial Instr_6

Fair Value of Financial Instruments (Quantitative Information about Level 3 Fair Value Measurements) (Details) $ in Thousands	Mar. 31, 2022USD ($)item	Dec. 31, 2021USD ($)item
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired Loans | $	$ 7,130	$ 14,796
Other Real Estate Owned | $	75	75
(Level 3) Significant Unobservable Inputs [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired Loans | $	7,130	14,796
Other Real Estate Owned | $	$ 75	$ 75
(Level 3) Significant Unobservable Inputs [Member] | Minimum [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired Loans, Range | item	0	0
Other Real Estate Owned, Range | item	0	0
(Level 3) Significant Unobservable Inputs [Member] | Maximum [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired Loans, Range | item	10	10
Other Real Estate Owned, Range | item	10	10

Fair Value of Financial Instr_7

Fair Value of Financial Instruments (Carrying Values and Estimated Fair Values of Financial Instruments) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available for sale	$ 86,307	$ 85,186
Carrying Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	396,653	411,629
Interest-earning time deposits	735	735
Debt securities available for sale	86,307	85,186
Equity investments	21,269	25,187
Loans held for sale	325	952
Loans receivable, net	2,395,930	2,304,942
FHLB of New York stock, at cost	6,128	6,084
Accrued interest receivable	9,593	9,183
Deposits	2,631,175	2,561,402
Debt	71,848	71,711
Subordinated debentures	37,333	37,275
Accrued interest payable	553	1,051
Fair Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	396,653	411,629
Interest-earning time deposits	735	735
Debt securities available for sale	86,307	85,186
Equity investments	21,269	25,187
Loans held for sale	325	952
Loans receivable, net	2,333,896	2,313,204
FHLB of New York stock, at cost	6,128	6,084
Accrued interest receivable	9,593	9,183
Deposits	2,532,283	2,520,191
Debt	68,572	71,214
Subordinated debentures	43,354	45,020
Accrued interest payable	553	1,051
(Level 1) Quoted Prices in Active Markets for Identical Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	396,653	411,629
Equity investments	21,269	25,187
Deposits	1,949,169	1,881,121
(Level 2) Significant Other Observable Inputs [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest-earning time deposits	735	735
Debt securities available for sale	86,307	85,186
Loans held for sale	325	952
FHLB of New York stock, at cost	6,128	6,084
Accrued interest receivable	9,593	9,183
Deposits	583,114	639,070
Debt	68,572	71,214
Subordinated debentures	43,354	45,020
Accrued interest payable	553	1,051
(Level 3) Significant Unobservable Inputs [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable, net	$ 2,333,896	$ 2,313,204

Subordinated Debt (Narrative) (

Subordinated Debt (Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Jul. 30, 2018
Trust Preferred Securities Subject to Mandatory Redemption [Member]
Subordinated Borrowing [Line Items]
Variable interest rate spread	2.65%
Trust preferred securities	$ 4,124,000
Fixed To Floating Rate Subordinated Debentures [Member]
Subordinated Borrowing [Line Items]
Face amount			$ 33,500,000
Notes term	10 years
Redemption restriction period	5 years
Deferred finance costs	$ 291,000	$ 349,000
Fixed To Floating Rate Subordinated Debentures [Member] | First Five Years [Member]
Subordinated Borrowing [Line Items]
Interest rate	5.625%
Fixed To Floating Rate Subordinated Debentures [Member] | After Five Years [Member]
Subordinated Borrowing [Line Items]
Variable interest rate spread	2.72%

Lease Obligations (Narrative) (

Lease Obligations (Narrative) (Details) - item	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Lessee, Lease, Description [Line Items]
Number of operating leases	28
Weighted average remaining lease term, operating leases	5 years 10 months 9 days	5 years 11 months 26 days
Weighted average discount rate, operating leases	2.58%	2.60%
Minimum [Member]
Lessee, Lease, Description [Line Items]
Remaining lease terms	1 year
Maximum [Member]
Lessee, Lease, Description [Line Items]
Remaining lease terms	10 years

Lease Obligations (Schedule of

Lease Obligations (Schedule of Lease Information) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Commitments and Contingencies [Abstract]
Operating lease cost	$ 902	$ 952
Variable lease cost-operating leases	218	246
Operating lease right-of-use assets	11,883		$ 12,457
Current liabilities	3,123		3,296
Operating lease liabilities (noncurrent portion)	10,057		10,529
Imputed interest	(1,000)	$ (1,073)	(1,073)
Total Operating Lease Liabilities	$ 12,180		$ 12,752

Lease Obligations (Summary of M

Lease Obligations (Summary of Maturity of Lease Obligations for Operating Leases) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
Commitments and Contingencies [Abstract]
One year or less	$ 3,123	$ 3,296
Over one year through three years	4,322	4,455
Over three years through five years	2,986	3,012
Over five years	2,749	3,062
Gross Operating Lease Liabilities	13,180	13,825
Imputed interest	(1,000)	(1,073)	$ (1,073)
Total Operating Lease Liabilities	$ 12,180	$ 12,752

Subsequent Events (Narrative) (

Subsequent Events (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands	May 01, 2022	Apr. 13, 2022	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Subsequent Event [Line Items]
Preferred stock redeemed, value			$ 5,330
Subsequent Event [Member]
Subsequent Event [Line Items]
Date declared		Apr. 13, 2022
Dividends per common share		$ 0.16
Date of record		May 2, 2022
Date paid		May 16, 2022
Series D Preferred Stock [Member]
Subsequent Event [Line Items]
Preferred stock, dividend rate			4.50%	4.50%	4.50%
Series D Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Preferred stock redeemed, shares	940
Preferred stock, dividend rate	4.50%
Preferred stock, redemption price	$ 10,000
Preferred stock redeemed, value	$ 9,400